Main Menu

Publications

Publications Highlights View all by category

Types of Publications


Journal Articles

Shu, X., Wu, L., Khankari, N.K., Shu, X.-., Wang, T.J., Michailidou, K., Bolla, M.K., Wang, Q., Dennis, J., Milne, R.L., et al. (2019). Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis. International journal of epidemiology, Vol.48 (3), pp. 795-806.  show abstract

Opstal-van Winden, A.W., de Haan, H.G., Hauptmann, M., Schmidt, M.K., Broeks, A., Russell, N.S., Janus, C.P., Krol, A.D., van der Baan, F.H., De Bruin, M.L., et al. (2019). Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma. Blood, Vol.133 (10), pp. 1130-1139.  show abstract

Jones, M.E., Schoemaker, M.J., McFadden, E.C., Wright, L.B., Johns, L.E. & Swerdlow, A.J. (2019). Night shift work and risk of breast cancer in women: the Generations Study cohort. British journal of cancer, Vol.121 (2), pp. 172-179.

Ferreira, M.A., Gamazon, E.R., Al-Ejeh, F., Aittomäki, K., Andrulis, I.L., Anton-Culver, H., Arason, A., Arndt, V., Aronson, K.J., Arun, B.K., et al. (2019). Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer. Nature communications, Vol.10 (1).

Law, P.J., Timofeeva, M., Fernandez-Rozadilla, C., Broderick, P., Studd, J., Fernandez-Tajes, J., Farrington, S., Svinti, V., Palles, C., Orlando, G., et al. (2019). Association analyses identify 31 new risk loci for colorectal cancer susceptibility. Nature communications, Vol.10 (1).

Schoemaker, M.J., Jones, M.E., Higgins, C.D., Wright, A.F., United Kingdom Clinical Cytogenetics, G. & Swerdlow, A.J. (2019). Mortality and Cancer Incidence in Carriers of Balanced Robertsonian Translocations: A National Cohort Study. Am j epidemiol, Vol.188, pp. 500-508.  show abstract

Mavaddat, N., Michailidou, K., Dennis, J., Lush, M., Fachal, L., Lee, A., Tyrer, J.P., Chen, T.H., Wang, Q., Bolla, M.K., et al. (2019). Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. Am j hum genet, Vol.104, pp. 21-34.  show abstract

Ruth, K.S., Soares, A.L., Borges, M.C., Eliassen, A.H., Hankinson, S.E., Jones, M.E., Kraft, P., Nichols, H.B., Sandler, D.P., Schoemaker, M.J., et al. (2019). Genome-wide association study of anti-Mullerian hormone levels in pre-menopausal women of late reproductive age and relationship with genetic determinants of reproductive lifespan. Hum mol genet, .  show abstract

Escala-Garcia, M., Guo, Q., Dork, T., Canisius, S., Keeman, R., Dennis, J., Beesley, J., Lecarpentier, J., Bolla, M.K., Wang, Q., et al. (2019). Genome-wide association study of germline variants and breast cancer-specific mortality. British journal of cancer, .  show abstract

Rudolph, A., Song, M., Brook, M.N., Milne, R.L., Mavaddat, N., Michailidou, K., Bolla, M.K., Wang, Q., Dennis, J., Wilcox, A.N., et al. (2018). Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium. International journal of epidemiology, Vol.47 (2), pp. 526-536.

Colombo, M., Lòpez-Perolio, I., Meeks, H.D., Caleca, L., Parsons, M.T., Li, H., De Vecchi, G., Tudini, E., Foglia, C., Mondini, P., et al. (2018). The BRCA2 c 68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. Human mutation, Vol.39 (5), pp. 729-741.

Colombo, M., Lopez-Perolio, I., Meeks, H.D., Caleca, L., Parsons, M.T., Li, H., De Vecchi, G., Tudini, E., Foglia, C., Mondini, P., et al. (2018). The BRCA2 c 68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. Human mutation, Vol.39 (5), pp. 729-741.

Deltour, I., Schlehofer, B., Massardier-Pilonchéry, A., Schlaefer, K., Armstrong, B., Giles, G.G., Siemiatycki, J., Parent, M.-., Krewski, D., McBride, M., et al. (2018). Exposure to loud noise and risk of vestibular schwannoma: results from the INTERPHONE international case‒control study. Scand j work environ health, .  show abstract

Johns, L.E., Swerdlow, A.J. & Moss, S.M. (2018). Effect of population breast screening on breast cancer mortality to 2005 in England and Wales: A nested case-control study within a cohort of one million women. Journal of medical screening, Vol.25 (2), pp. 76-81.

Swerdlow, A.J., Harvey, C.E., Milne, R.L., Pottinger, C.A., Vachon, C.M., Wilkens, L.R., Gapstur, S.M., Johansson, M., Weiderpass, E. & Winn, D.M., et al. (2018). The National Cancer Institute Cohort Consortium: An International Pooling Collaboration of 58 Cohorts from 20 Countries. Cancer epidemiology biomarkers & prevention, Vol.27 (11), pp. 1307-1319.

Nichols, H.B., Schoemaker, M.J., Cai, J., Xu, J., Wright, L.B., Brook, M.N., Jones, M.E., Adami, H.-., Baglietto, L., Bertrand, K.A., et al. (2018). Breast Cancer Risk After Recent Childbirth: A Pooled Analysis of 15 Prospective Studies. Ann intern med, .  show abstract

Zhang, T., Choi, J., Kovacs, M.A., Shi, J., Xu, M., Goldstein, A.M., Trower, A.J., Bishop, D.T., Iles, M.M., Duffy, D.L., et al. (2018). Cell-type–specific eQTL of primary melanocytes facilitates identification of melanoma susceptibility genes. Genome research, Vol.28 (11), pp. 1621-1635.

O’Mara, T.A., Glubb, D.M., Amant, F., Annibali, D., Ashton, K., Attia, J., Auer, P.L., Beckmann, M.W., Black, A., Bolla, M.K., et al. (2018). Identification of nine new susceptibility loci for endometrial cancer. Nature communications, Vol.9 (1).

Lu, Y., Beeghly-Fadiel, A., Wu, L., Guo, X., Li, B., Schildkraut, J.M., Im, H.K., Chen, Y.A., Permuth, J.B., Reid, B.M., et al. (2018). A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. Cancer research, Vol.78 (18), pp. 5419-5430.

Ong, J.S., Hwang, L.D., Cuellar-Partida, G., Martin, N.G., Chenevix-Trench, G., Quinn, M.C., Cornelis, M.C., Gharahkhani, P., Webb, P.M., MacGregor, S., et al. (2018). Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: a Mendelian randomization study. Int j epidemiol, Vol.47, pp. 450-459.  show abstract

Johns, L.E., Jones, M.E., Schoemaker, M.J., McFadden, E., Ashworth, A. & Swerdlow, A.J. (2018). Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study. Br j cancer, Vol.118, pp. 600-606.  show abstract

Abubakar, M., Chang-Claude, J., Ali, H.R., Chatterjee, N., Coulson, P., Daley, F., Blows, F., Benitez, J., Milne, R.L., Brenner, H., et al. (2018). Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation. Int j cancer, Vol.143, pp. 746-757.  show abstract

Wright, L.B., Schoemaker, M.J., Jones, M.E., Ashworth, A. & Swerdlow, A.J. (2018). Breast cancer risk in relation to history of preeclampsia and hyperemesis gravidarum: Prospective analysis in the Generations Study. Int j cancer, Vol.143, pp. 782-792.  show abstract

Trabert, B., Poole, E.M., White, E., Visvanathan, K., Adami, H.O., Anderson, G.L., Brasky, T.M., Brinton, L.A., Fortner, R.T., Gaudet, M., et al. (2018). Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium. J natl cancer inst, , p. [Epub ahead of print].  show abstract

Horne, H.N., Oh, H., Sherman, M.E., Palakal, M., Hewitt, S.M., Schmidt, M.K., Milne, R.L., Hardisson, D., Benitez, J., Blomqvist, C., et al. (2018). E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium. Sci rep, Vol.8, p. 6574.  show abstract

Wu, L., Shi, W., Long, J., Guo, X., Michailidou, K., Beesley, J., Bolla, M.K., Shu, X.O., Lu, Y., Cai, Q., et al. (2018). A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer. Nat genet, , pp. 968-978.  show abstract

Swerdlow, A.J., Wright, L.B., Schoemaker, M.J. & Jones, M.E. (2018). Maternal breast cancer risk in relation to birthweight and gestation of her offspring. Breast cancer research : bcr, Vol.20, p. 110.  show abstract

Schoemaker, M.J., Jones, M.E., Higgins, C.D., Wright, A.F., Group, U.K. & Swerdlow, A.J. (2018). Mortality and cancer incidence in carriers of constitutional t(11;22)(q23;q11) translocations: A prospective study. Int j cancer, .  show abstract

Rambau, P.F., Vierkant, R.A., Intermaggio, M.P., Kelemen, L.E., Goodman, M.T., Herpel, E., Pharoah, P.D., Kommoss, S., Jimenez-Linan, M., Karlan, B.Y., et al. (2018). Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study. The journal of pathology clinical research, Vol.4, pp. 250-261.  show abstract

Williams, C.L., Jones, M.E., Swerdlow, A.J., Botting, B.J., Davies, M.C., Jacobs, I., Bunch, K.J., Murphy, M.F. & Sutcliffe, A.G. (2018). Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2 2 million person years of observation. Br med j, Vol.362, p. k2644.

McCullough, M.L., Zoltick, E.S., Weinstein, S.J., Fedirko, V., Wang, M., Cook, N.R., Eliassen, A.H., Zeleniuch-Jacquotte, A., Agnoli, C., Albanes, D., et al. (2018). Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts. J natl cancer inst, , p. [Epub ahead of print].  show abstract

Johns, L.E., Coleman, D.A., Swerdlow, A.J. & Moss, S.M. (2017). Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study. British journal of cancer, Vol.116 (2), pp. 246-252.

Swerdlow, A.J., Cooke, R., Beckers, D., Borgström, B., Butler, G., Carel, J.-., Cianfarani, S., Clayton, P., Coste, J., Deodati, A., et al. (2017). Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study. The journal of clinical endocrinology & metabolism, Vol.102 (5), pp. 1661-1672.

Barrdahl, M., Rudolph, A., Hopper, J.L., Southey, M.C., Broeks, A., Fasching, P.A., Beckmann, M.W., Gago-Dominguez, M., Castelao, J.E., Guénel, P., et al. (2017). Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium. International journal of cancer, Vol.141 (9), pp. 1830-1840.

Shimelis, H., Mesman, R.L., Von Nicolai, C., Ehlen, A., Guidugli, L., Martin, C., Calléja, F.M., Meeks, H., Hallberg, E., Hinton, J., et al. (2017). BRCA2Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer. Cancer research, Vol.77 (11), pp. 2789-2799.

Muranen, T.A., Greco, D., Blomqvist, C., Aittomäki, K., Khan, S., Hogervorst, F., Verhoef, S., Pharoah, P.D., Dunning, A.M., Shah, M., et al. (2017). Genetic modifiers of CHEK2*1100delC-associated breast cancer risk. Genetics in medicine, Vol.19 (5), pp. 599-603.

Melin, B.S., Barnholtz-Sloan, J.S., Wrensch, M.R., Johansen, C., Il'yasova, D., Kinnersley, B., Ostrom, Q.T., Labreche, K., Chen, Y., Armstrong, G., et al. (2017). Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors. Nature genetics, Vol.49 (5), pp. 789-794.

Russell, N.S., Krul, I.M., van Eggermond, A.M., Aleman, B.M., Cooke, R., Kuiper, S., Allen, S.D., Wallis, M.G., Llanas, D., Diallo, I., et al. (2017). Retrospective methods to estimate radiation dose at the site of breast cancer development after Hodgkin lymphoma radiotherapy. Clinical and translational radiation oncology, Vol.7, pp. 20-27.

Schoemaker, M.J., Jones, M.E., Allen, S., Hoare, J., Ashworth, A., Dowsett, M. & Swerdlow, A.J. (2017). Childhood body size and pubertal timing in relation to adult mammographic density phenotype. Breast cancer res, Vol.19, p. 13.  show abstract

Phelan, C.M., Kuchenbaecker, K.B., Tyrer, J.P., Kar, S.P., Lawrenson, K., Winham, S.J., Dennis, J., Pirie, A., Riggan, M.J., Chornokur, G., et al. (2017). Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. Nat genet, Vol.49, pp. 680-691.  show abstract

Brewer, H.R., Jones, M.E., Schoemaker, M.J., Ashworth, A. & Swerdlow, A.J. (2017). Family history and risk of breast cancer: an analysis accounting for family structure. Breast cancer res treat, Vol.165, pp. 193-200.  show abstract

Nichols, H.B., Schoemaker, M.J., Wright, L.B., McGowan, C., Brook, M.N., McClain, K.M., Jones, M.E., Adami, H.O., Agnoli, C., Baglietto, L., et al. (2017). The Premenopausal Breast Cancer Collaboration: A Pooling Project of Studies Participating in the National Cancer Institute Cohort Consortium. Cancer epidemiol biomarkers prev, Vol.26, pp. 1360-1369.  show abstract

Milne, R.L., Kuchenbaecker, K.B., Michailidou, K., Beesley, J., Kar, S., Lindstrom, S., Hui, S., Lemacon, A., Soucy, P., Dennis, J., et al. (2017). Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. Nat genet, Vol.49, pp. 1767-1778.  show abstract

Brouckaert, O., Rudolph, A., Laenen, A., Keeman, R., Bolla, M.K., Wang, Q., Soubry, A., Wildiers, H., Andrulis, I.L., Arndt, V., et al. (2017). Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. Breast cancer res, Vol.19, p. 119.  show abstract

Jones, M.E., Schoemaker, M.J., Wright, L.B., Ashworth, A. & Swerdlow, A.J. (2017). Smoking and risk of breast cancer in the Generations Study cohort. Breast cancer res, Vol.19, p. 118.  show abstract

Michailidou, K., Lindstrom, S., Dennis, J., Beesley, J., Hui, S., Kar, S., Lemacon, A., Soucy, P., Glubb, D., Rostamianfar, A., et al. (2017). Association analysis identifies 65 new breast cancer risk loci. Nature, Vol.551, pp. 92-94.  show abstract

Jiao, X., Aravidis, C., Marikkannu, R., Rantala, J., Picelli, S., Adamovic, T., Liu, T., Maguire, P., Kremeyer, B., Luo, L., et al. (2017). PHIP - a novel candidate breast cancer susceptibility locus on 6q14 1. Oncotarget, Vol.8, pp. 102769-102782.  show abstract

Wyszynski, A., Hong, C.-., Lam, K., Michailidou, K., Lytle, C., Yao, S., Zhang, Y., Bolla, M.K., Wang, Q., Dennis, J., et al. (2016). An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression. Human molecular genetics, Vol.25 (17), pp. 3863-3876.

Painter, J.N., O'Mara, T.A., Marquart, L., Webb, P.M., Attia, J., Medland, S.E., Cheng, T., Dennis, J., Holliday, E.G., McEvoy, M., et al. (2016). Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer. Cancer epidemiology biomarkers & prevention, Vol.25 (11), pp. 1503-1510.

Thompson, D.J., O'Mara, T.A., Glubb, D.M., Painter, J.N., Cheng, T., Folkerd, E., Doody, D., Dennis, J., Webb, P.M., _, _., et al. (2016). CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer. Endocrine-related cancer, Vol.23 (2), pp. 77-91.  show abstract

Allen, D.B., Backeljauw, P., Bidlingmaier, M., Biller, B.M., Boguszewski, M., Burman, P., Butler, G., Chihara, K., Christiansen, J., Cianfarani, S., et al. (2016). GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults. European journal of endocrinology, Vol.174 (2), pp. P1-P9.  show abstract

Dunning, A.M., Michailidou, K., Kuchenbaecker, K.B., Thompson, D., French, J.D., Beesley, J., Healey, C.S., Kar, S., Pooley, K.A., Lopez-Knowles, E., et al. (2016). Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. Nature genetics, Vol.48 (4), pp. 374-386.

Hollestelle, A., van der Baan, F.H., Berchuck, A., Johnatty, S.E., Aben, K.K., Agnarsson, B.A., Aittomäki, K., Alducci, E., Andrulis, I.L., Anton-Culver, H., et al. (2016). No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic oncology, Vol.141 (2), pp. 386-401.

Kinnersley, B., Kamatani, Y., Labussière, M., Wang, Y., Galan, P., Mokhtari, K., Delattre, J.-., Gousias, K., Schramm, J., Schoemaker, M.J., et al. (2016). Search for new loci and low-frequency variants influencing glioma risk by exome-array analysis. European journal of human genetics, Vol.24 (5), pp. 717-724.

Zhao, Z., Wen, W., Michailidou, K., Bolla, M.K., Wang, Q., Zhang, B., Long, J., Shu, X.-., Schmidt, M.K., Milne, R.L., et al. (2016). Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry. Cancer causes & control, Vol.27 (5), pp. 679-693.

Cheng, T.H., Thompson, D.J., O'Mara, T.A., Painter, J.N., Glubb, D.M., Flach, S., Lewis, A., French, J.D., Freeman-Mills, L., Church, D., et al. (2016). Five endometrial cancer risk loci identified through genome-wide association analysis. Nature genetics, Vol.48 (6), pp. 667-674.

Petridis, C., Brook, M.N., Shah, V., Kohut, K., Gorman, P., Caneppele, M., Levi, D., Papouli, E., Orr, N., Cox, A., et al. (2016). Genetic predisposition to ductal carcinoma in situ of the breast. Breast cancer research, Vol.18 (1).

Shi, J., Zhang, Y., Zheng, W., Michailidou, K., Ghoussaini, M., Bolla, M.K., Wang, Q., Dennis, J., Lush, M., Milne, R.L., et al. (2016). Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer. International journal of cancer, Vol.139 (6), pp. 1303-1317.

Mitchell, J.S., Li, N., Weinhold, N., Försti, A., Ali, M., Van Duin, M., Thorleifsson, G., Johnson, D.C., Chen, B., Halvarsson, B.-., et al. (2016). Genome-wide association study identifies multiple susceptibility loci for multiple myeloma. Nature communications, Vol.7.

Lei, J., Rudolph, A., Moysich, K.B., Behrens, S., Goode, E.L., Bolla, M.K., Dennis, J., Dunning, A.M., Easton, D.F., Wang, Q., et al. (2016). Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium. Hum genet, Vol.135, pp. 137-154.  show abstract

Meeks, H.D., Song, H., Michailidou, K., Bolla, M.K., Dennis, J., Wang, Q., Barrowdale, D., Frost, D., Embrace, , McGuffog, L., et al. (2016). BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. J natl cancer inst, Vol.108.  show abstract

Couch, F.J., Kuchenbaecker, K.B., Michailidou, K., Mendoza-Fandino, G.A., Nord, S., Lilyquist, J., Olswold, C., Hallberg, E., Agata, S., Ahsan, H., et al. (2016). Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer. Nat commun, Vol.7, p. 11375.  show abstract

Easton, D.F., Lesueur, F., Decker, B., Michailidou, K., Li, J., Allen, J., Luccarini, C., Pooley, K.A., Shah, M., Bolla, M.K., et al. (2016). No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing. J med genet, Vol.53, pp. 298-309.  show abstract

Schoemaker, M.J., Jones, M.E., Wright, L.B., Griffin, J., McFadden, E., Ashworth, A. & Swerdlow, A.J. (2016). Psychological stress, adverse life events and breast cancer incidence: a cohort investigation in 106,000 women in the United Kingdom. Breast cancer res, Vol.18, p. 72.  show abstract

Kar, S.P., Beesley, J., Amin Al Olama, A., Michailidou, K., Tyrer, J., Kote-Jarai, Z., Lawrenson, K., Lindstrom, S., Ramus, S.J., Thompson, D.J., et al. (2016). Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. Cancer discov, Vol.6, pp. 1052-1067.  show abstract

Jones, M.E., Schoemaker, M.J., Wright, L., McFadden, E., Griffin, J., Thomas, D., Hemming, J., Wright, K., Ashworth, A. & Swerdlow, A.J., et al. (2016). Menopausal hormone therapy and breast cancer: what is the true size of the increased risk?. Br j cancer, Vol.115, pp. 607-615.  show abstract

Abubakar, M., Howat, W.J., Daley, F., Zabaglo, L., McDuffus, L.A., Blows, F., Coulson, P., Raza Ali, H., Benitez, J., Milne, R., et al. (2016). High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium. J pathol clin res, Vol.2, pp. 138-153.  show abstract

Southey, M.C., Goldgar, D.E., Winqvist, R., Pylkas, K., Couch, F., Tischkowitz, M., Foulkes, W.D., Dennis, J., Michailidou, K., van Rensburg, E.J., et al. (2016). PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. J med genet, Vol.53, pp. 800-811.  show abstract

Wentzensen, N., Poole, E.M., Trabert, B., White, E., Arslan, A.A., Patel, A.V., Setiawan, V.W., Visvanathan, K., Weiderpass, E., Adami, H.O., et al. (2016). Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium. J clin oncol, Vol.34, pp. 2888-2898.  show abstract

Hamdi, Y., Soucy, P., Adoue, V., Michailidou, K., Canisius, S., Lemacon, A., Droit, A., Andrulis, I.L., Anton-Culver, H., Arndt, V., et al. (2016). Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. Oncotarget, Vol.7, pp. 80140-80163.  show abstract

Abubakar, M., Orr, N., Daley, F., Coulson, P., Ali, H.R., Blows, F., Benitez, J., Milne, R., Brenner, H., Stegmaier, C., et al. (2016). Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups. Breast cancer res, Vol.18, p. 104.  show abstract

Zeng, C., Guo, X., Long, J., Kuchenbaecker, K.B., Droit, A., Michailidou, K., Ghoussaini, M., Kar, S., Freeman, A., Hopper, J.L., et al. (2016). Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus. Breast cancer res, Vol.18, p. 64.  show abstract

Schmidt, M.K., Hogervorst, F., van Hien, R., Cornelissen, S., Broeks, A., Adank, M.A., Meijers, H., Waisfisz, Q., Hollestelle, A., Schutte, M., et al. (2016). Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers. J clin oncol, Vol.34, pp. 2750-2760.  show abstract

Guo, Y., Warren Andersen, S., Shu, X.O., Michailidou, K., Bolla, M.K., Wang, Q., Garcia-Closas, M., Milne, R.L., Schmidt, M.K., Chang-Claude, J., et al. (2016). Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent. Plos med, Vol.13, p. e1002105.  show abstract

Lin, W.-., Camp, N.J., Ghoussaini, M., Beesley, J., Michailidou, K., Hopper, J.L., Apicella, C., Southey, M.C., Stone, J., Schmidt, M.K., et al. (2015). Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk. Hum mol genet, Vol.24 (1), pp. 285-298.  show abstract

Flanagan, J.M., Brook, M.N., Orr, N., Tomczyk, K., Coulson, P., Fletcher, O., Jones, M.E., Schoemaker, M.J., Ashworth, A., Swerdlow, A., et al. (2015). Temporal stability and determinants of white blood cell DNA methylation in the breakthrough generations study. Cancer epidemiol biomarkers prev, Vol.24 (1), pp. 221-229.  show abstract

Painter, J.N., O'Mara, T.A., Batra, J., Cheng, T., Lose, F.A., Dennis, J., Michailidou, K., Tyrer, J.P., Ahmed, S., Ferguson, K., et al. (2015). Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk. Human molecular genetics, Vol.24 (5), pp. 1478-1492.

Davies, J.R., Chang, Y.-., Bishop, D.T., Armstrong, B.K., Bataille, V., Bergman, W., Berwick, M., Bracci, P.M., Elwood, J.M., Ernstoff, M.S., et al. (2015). Development and Validation of a Melanoma Risk Score Based on Pooled Data from 16 Case-Control Studies. Cancer epidemiology biomarkers & prevention, Vol.24 (5), pp. 817-824.

Guo, X., Long, J., Zeng, C., Michailidou, K., Ghoussaini, M., Bolla, M.K., Wang, Q., Milne, R.L., Shu, X.-., Cai, Q., et al. (2015). Fine-Scale Mapping of the 4q24 Locus Identifies Two Independent Loci Associated with Breast Cancer Risk. Cancer epidemiology biomarkers & prevention, Vol.24 (11), pp. 1680-1691.

Kabisch, M., Lorenzo Bermejo, J., Dünnebier, T., Ying, S., Michailidou, K., Bolla, M.K., Wang, Q., Dennis, J., Shah, M., Perkins, B.J., et al. (2015). Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer. Carcinogenesis, Vol.36 (2), pp. 256-271.  show abstract

Carvajal-Carmona, L.G., O’Mara, T.A., Painter, J.N., Lose, F.A., Dennis, J., Michailidou, K., Tyrer, J.P., Ahmed, S., Ferguson, K., Healey, C.S., et al. (2015). Candidate locus analysis of the TERT–CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk. Human genetics, Vol.134 (2), pp. 231-245.

Cook, M.B., Guénel, P., Gapstur, S.M., van den Brandt, P.A., Michels, K.B., Casagrande, J.T., Cooke, R., Van Den Eeden, S.K., Ewertz, M., Falk, R.T., et al. (2015). Tobacco and alcohol in relation to male breast cancer: an analysis of the male breast cancer pooling project consortium. Cancer epidemiol biomarkers prev, Vol.24 (3), pp. 520-531.  show abstract

Michailidou, K., Beesley, J., Lindstrom, S., Canisius, S., Dennis, J., Lush, M.J., Maranian, M.J., Bolla, M.K., Wang, Q., Shah, M., et al. (2015). Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer. Nature genetics, Vol.47 (4), pp. 373-380.

Mavaddat, N., Pharoah, P.D., Michailidou, K., Tyrer, J., Brook, M.N., Bolla, M.K., Wang, Q., Dennis, J., Dunning, A.M., Shah, M., et al. (2015). Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants. Jnci: journal of the national cancer institute, Vol.107 (5).

Darabi, H., McCue, K., Beesley, J., Michailidou, K., Nord, S., Kar, S., Humphreys, K., Thompson, D., Ghoussaini, M., Bolla, M.K., et al. (2015). Polymorphisms in a Putative Enhancer at the 10q21 2 Breast Cancer Risk Locus Regulate NRBF2 Expression. The american journal of human genetics, Vol.97 (1), pp. 22-34.

Glubb, D.M., Maranian, M.J., Michailidou, K., Pooley, K.A., Meyer, K.B., Kar, S., Carlebur, S., O'Reilly, M., Betts, J.A., Hillman, K.M., et al. (2015). Fine-scale mapping of the 5q11 2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. Am j hum genet, Vol.96 (1), pp. 5-20.  show abstract

Law, M.H., Bishop, D.T., Lee, J.E., Brossard, M., Martin, N.G., Moses, E.K., Song, F., Barrett, J.H., Kumar, R., Easton, D.F., et al. (2015). Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma. Nature genetics, Vol.47 (9), pp. 987-995.

Savage, P., Cooke, R., O'Nions, J., Krell, J., Kwan, A., Camarata, M., Dancy, G., Short, D., Seckl, M.J. & Swerdlow, A., et al. (2015). Effects of single-agent and combination chemotherapy for gestational trophoblastic tumors on risks of second malignancy and early menopause. J clin oncol, Vol.33 (5), pp. 472-478.  show abstract

O'Mara, T.A., Glubb, D.M., Painter, J.N., Cheng, T., Dennis, J., _, _., Attia, J., Holliday, E.G., McEvoy, M., Scott, R.J., et al. (2015). Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer. Endocrine-related cancer, Vol.22 (5), pp. 851-861.  show abstract

Sud, A., Cooke, R., Swerdlow, A.J. & Houlston, R.S. (2015). Genome-wide homozygosity signature and risk of Hodgkin lymphoma. Scientific reports, Vol.5 (1).

Day, F.R., Ruth, K.S., Thompson, D.J., Lunetta, K.L., Pervjakova, N., Chasman, D.I., Stolk, L., Finucane, H.K., Sulem, P., Bulik-Sullivan, B., et al. (2015). Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair. Nature genetics, Vol.47 (11), pp. 1294-1303.

Cheng, T.H., Thompson, D., Painter, J., O’Mara, T., Gorman, M., Martin, L., Palles, C., Jones, A., Buchanan, D.D., Win, A.K., et al. (2015). Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1. Scientific reports, Vol.5 (1).

Day, F.R., Ruth, K.S., Thompson, D.J., Lunetta, K.L., Pervjakova, N., Chasman, D.I., Stolk, L., Finucane, H.K., Sulem, P., Bulik-Sullivan, B., et al. (2015). Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair. Obstetrical & gynecological survey, Vol.70 (12), pp. 758-762.

Rudolph, A., Milne, R.L., Truong, T., Knight, J.A., Seibold, P., Flesch-Janys, D., Behrens, S., Eilber, U., Bolla, M.K., Wang, Q., et al. (2015). Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors. International journal of cancer, Vol.136 (6), pp. E685-E696.

Orr, N., Dudbridge, F., Dryden, N., Maguire, S., Novo, D., Perrakis, E., Johnson, N., Ghoussaini, M., Hopper, J.L., Southey, M.C., et al. (2015). Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31 2. Hum mol genet, Vol.24, pp. 2966-2984.  show abstract

van Veldhoven, K., Polidoro, S., Baglietto, L., Severi, G., Sacerdote, C., Panico, S., Mattiello, A., Palli, D., Masala, G., Krogh, V., et al. (2015). Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis. Clin epigenetics, Vol.7, p. 67.  show abstract

Lemnrau, A., Brook, M.N., Fletcher, O., Coulson, P., Tomczyk, K., Jones, M., Ashworth, A., Swerdlow, A., Orr, N. & Garcia-Closas, M., et al. (2015). Mitochondrial DNA Copy Number in Peripheral Blood Cells and Risk of Developing Breast Cancer. Cancer res, Vol.75, pp. 2844-2850.  show abstract

Swerdlow, A.J., Cooke, R., Albertsson-Wikland, K., Borgström, B., Butler, G., Cianfarani, S., Clayton, P., Coste, J., Deodati, A., Ecosse, E., et al. (2015). Description of the SAGhE Cohort: A Large European Study of Mortality and Cancer Incidence Risks after Childhood Treatment with Recombinant Growth Hormone. Hormone research in paediatrics, Vol.84 (3), pp. 172-183.

Zhang, B., Shu, X.O., Delahanty, R.J., Zeng, C., Michailidou, K., Bolla, M.K., Wang, Q., Dennis, J., Wen, W., Long, J., et al. (2015). Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization. J natl cancer inst, Vol.107.  show abstract

Murray, A., Schoemaker, M.J., Bennett, C.E., Ennis, S., Macpherson, J.N., Jones, M., Morris, D.H., Orr, N., Ashworth, A., Jacobs, P.A., et al. (2014). Population-based estimates of the prevalence of FMR1 expansion mutations in women with early menopause and primary ovarian insufficiency. Genet med, Vol.16 (1), pp. 19-24.  show abstract

Schoeps, A., Rudolph, A., Seibold, P., Dunning, A.M., Milne, R.L., Bojesen, S.E., Swerdlow, A., Andrulis, I., Brenner, H., Behrens, S., et al. (2014). Identification of New Genetic Susceptibility Loci for Breast Cancer Through Consideration of Gene-Environment Interactions. Genetic epidemiology, Vol.38 (1), pp. 84-93.

Milne, R.L., Herranz, J., Michailidou, K., Dennis, J., Tyrer, J.P., Zamora, M.P., Arias-Perez, J.I., González-Neira, A., Pita, G., Alonso, M.R., et al. (2014). A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium. Hum mol genet, Vol.23 (7), pp. 1934-1946.  show abstract

Jones, M.E., Schoemaker, M.J., Rae, M., Folkerd, E.J., Dowsett, M., Ashworth, A. & Swerdlow, A.J. (2014). Reproducibility of estradiol and testosterone levels in postmenopausal women over 5 years: results from the breakthrough generations study. Am j epidemiol, Vol.179 (9), pp. 1128-1133.  show abstract

McFadden, E., Jones, M.E., Schoemaker, M.J., Ashworth, A. & Swerdlow, A.J. (2014). The relationship between obesity and exposure to light at night: cross-sectional analyses of over 100,000 women in the Breakthrough Generations Study. Am j epidemiol, Vol.180 (3), pp. 245-250.  show abstract

Perry, J.R., Hsu, Y.-., Chasman, D.I., Johnson, A.D., Elks, C., Albrecht, E., Andrulis, I.L., Beesley, J., Berenson, G.S., Bergmann, S., et al. (2014). DNA mismatch repair gene MSH6 implicated in determining age at natural menopause. Human molecular genetics, Vol.23 (9), pp. 2490-2497.

Schoemaker, M.J., Folkerd, E.J., Jones, M.E., Rae, M., Allen, S., Ashworth, A., Dowsett, M. & Swerdlow, A.J. (2014). Combined effects of endogenous sex hormone levels and mammographic density on postmenopausal breast cancer risk: results from the Breakthrough Generations Study. Br j cancer, Vol.110 (7), pp. 1898-1907.  show abstract

Brinton, L.A., Cook, M.B., McCormack, V., Johnson, K.C., Olsson, H., Casagrande, J.T., Cooke, R., Falk, R.T., Gapstur, S.M., Gaudet, M.M., et al. (2014). Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results. J natl cancer inst, Vol.106 (3), p. djt465.  show abstract

(2014). Guidelines for Limiting Exposure to Electric Fields Induced by Movement of the Human Body in a Static Magnetic Field and by Time-Varying Magnetic Fields below 1 Hz. Health physics, Vol.106 (3), pp. 418-425.

Sawyer, E., Roylance, R., Petridis, C., Brook, M.N., Nowinski, S., Papouli, E., Fletcher, O., Pinder, S., Hanby, A., Kohut, K., et al. (2014). Genetic predisposition to in situ and invasive lobular carcinoma of the breast. Plos genet, Vol.10 (4), p. e1004285.  show abstract

Bodicoat, D.H., Schoemaker, M.J., Jones, M.E., McFadden, E., Griffin, J., Ashworth, A. & Swerdlow, A.J. (2014). Timing of pubertal stages and breast cancer risk: the Breakthrough Generations Study. Breast cancer res, Vol.16 (1), p. R18.  show abstract

Morton, L.M., Swerdlow, A.J., Schaapveld, M., Ramadan, S., Hodgson, D.C., Radford, J. & van Leeuwen, F.E. (2014). Current knowledge and future research directions in treatment-related second primary malignancies. European journal of cancer supplements, Vol.12 (1), pp. 5-17.

Allen, S.D., Wallis, M.G., Cooke, R. & Swerdlow, A.J. (2014). Radiologic features of breast cancer after mantle radiation therapy for Hodgkin disease: a study of 230 cases. Radiology, Vol.272 (1), pp. 73-78.  show abstract

Swerdlow, A.J., Cooke, R., Bates, A., Cunningham, D., Falk, S.J., Gilson, D., Hancock, B.W., Harris, S.J., Horwich, A., Hoskin, P.J., et al. (2014). Risk of premature menopause after treatment for Hodgkin's lymphoma. J natl cancer inst, Vol.106 (9).  show abstract

Purrington, K.S., Slettedahl, S., Bolla, M.K., Michailidou, K., Czene, K., Nevanlinna, H., Bojesen, S.E., Andrulis, I.L., Cox, A., Hall, P., et al. (2014). Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade. Hum mol genet, Vol.23 (22), pp. 6034-6046.  show abstract

Milne, R.L., Burwinkel, B., Michailidou, K., Arias-Perez, J.-., Zamora, M.P., Menéndez-Rodríguez, P., Hardisson, D., Mendiola, M., González-Neira, A., Pita, G., et al. (2014). Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium. Hum mol genet, Vol.23 (22), pp. 6096-6111.  show abstract

Wang, Z., Zhu, B., Zhang, M., Parikh, H., Jia, J., Chung, C.C., Sampson, J.N., Hoskins, J.W., Hutchinson, A., Burdette, L., et al. (2014). Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15 33. Hum mol genet, Vol.23 (24), pp. 6616-6633.  show abstract

Agarwal, D., Pineda, S., Michailidou, K., Herranz, J., Pita, G., Moreno, L.T., Alonso, M.R., Dennis, J., Wang, Q., Bolla, M.K., et al. (2014). FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium. British journal of cancer, Vol.110 (4), pp. 1088-1100.

Ghoussaini, M., Edwards, S.L., Michailidou, K., Nord, S., Cowper-Sal Lari, R., Desai, K., Kar, S., Hillman, K.M., Kaufmann, S., Glubb, D.M., et al. (2014). Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. Nat commun, Vol.4, p. 4999.  show abstract

Johnson, N., Dudbridge, F., Orr, N., Gibson, L., Jones, M.E., Schoemaker, M.J., Folkerd, E.J., Haynes, B.P., Hopper, J.L., Southey, M.C., et al. (2014). Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study. Breast cancer res, Vol.16, p. R51.  show abstract

Khan, S., Greco, D., Michailidou, K., Milne, R.L., Muranen, T.A., Heikkinen, T., Aaltonen, K., Dennis, J., Bolla, M.K., Liu, J., et al. (2014). MicroRNA related polymorphisms and breast cancer risk. Plos one, Vol.9 (11), p. e109973.  show abstract

Enciso-Mora, V., Hosking, F.J., Kinnersley, B., Wang, Y., Shete, S., Zelenika, D., Broderick, P., Idbaih, A., Delattre, J.-., Hoang-Xuan, K., et al. (2013). Deciphering the 8q24 21 association for glioma. Hum mol genet, Vol.22 (11), pp. 2293-2302.  show abstract

Perry, J.R., Corre, T., Esko, T., Chasman, D.I., Fischer, K., Franceschini, N., He, C., Kutalik, Z., Mangino, M., Rose, L.M., et al. (2013). A genome-wide association study of early menopause and the combined impact of identified variants. Hum mol genet, Vol.22 (7), pp. 1465-1472.  show abstract

Garcia-Closas, M., Couch, F.J., Lindstrom, S., Michailidou, K., Schmidt, M.K., Brook, M.N., Orr, N., Rhie, S.K., Riboli, E., Feigelson, H.S., et al. (2013). Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat genet, Vol.45 (4), pp. 392-398e2.  show abstract

Bojesen, S.E., Pooley, K.A., Johnatty, S.E., Beesley, J., Michailidou, K., Tyrer, J.P., Edwards, S.L., Pickett, H.A., Shen, H.C., Smart, C.E., et al. (2013). Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nature genetics, Vol.45 (4), pp. 371-384.

French, J.D., Ghoussaini, M., Edwards, S.L., Meyer, K.B., Michailidou, K., Ahmed, S., Khan, S., Maranian, M.J., O'Reilly, M., Hillman, K.M., et al. (2013). Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am j hum genet, Vol.92 (4), pp. 489-503.  show abstract

Jacobs, P.A., Maloney, V., Cooke, R., Crolla, J.A., Ashworth, A. & Swerdlow, A.J. (2013). Male breast cancer, age and sex chromosome aneuploidy. British journal of cancer, Vol.108 (4), pp. 959-963.

Meyer, K.B., O'Reilly, M., Michailidou, K., Carlebur, S., Edwards, S.L., French, J.D., Prathalingham, R., Dennis, J., Bolla, M.K., Wang, Q., et al. (2013). Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. Am j hum genet, Vol.93 (6), pp. 1046-1060.  show abstract

(2013). ICNIRP Guidelines on Limits of Exposure to Laser Radiation of Wavelengths between 180 nm and 1,000 μm. Health physics, Vol.105 (3), pp. 271-295.

Cooke, R., Jones, M.E., Cunningham, D., Falk, S.J., Gilson, D., Hancock, B.W., Harris, S.J., Horwich, A., Hoskin, P.J., Illidge, T., et al. (2013). Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors. Br j cancer, Vol.108 (11), pp. 2399-2406.  show abstract

Rudolph, A., Hein, R., Lindström, S., Beckmann, L., Behrens, S., Liu, J., Aschard, H., Bolla, M.K., Wang, J., Truong, T., et al. (2013). Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study. Endocr relat cancer, Vol.20 (6), pp. 875-887.  show abstract

Enciso-Mora, V., Hosking, F.J., Di Stefano, A.L., Zelenika, D., Shete, S., Broderick, P., Idbaih, A., Delattre, J.-., Hoang-Xuan, K., Marie, Y., et al. (2013). Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222. Br j cancer, Vol.108 (10), pp. 2178-2185.  show abstract

Jones, M.E., Schoemaker, M., Rae, M., Folkerd, E.J., Dowsett, M., Ashworth, A. & Swerdlow, A.J. (2013). Changes in estradiol and testosterone levels in postmenopausal women after changes in body mass index. J clin endocrinol metab, Vol.98, pp. 2967-2974.  show abstract

Michailidou, K., Hall, P., Gonzalez-Neira, A., Ghoussaini, M., Dennis, J., Milne, R.L., Schmidt, M.K., Chang-Claude, J., Bojesen, S.E., Bolla, M.K., et al. (2013). Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat genet, Vol.45, pp. 353-361e2.  show abstract

Frampton, M., da Silva Filho, M.I., Broderick, P., Thomsen, H., Försti, A., Vijayakrishnan, J., Cooke, R., Enciso-Mora, V., Hoffmann, P., Nöthen, M.M., et al. (2013). Variation at 3p24 1 and 6q23 3 influences the risk of Hodgkin's lymphoma. Nat commun, Vol.4, p. 2549.  show abstract

Swerdlow, A.J. (2012). Epidemiology of long-term health effects of RF exposure. Mutagenesis, Vol.27, pp. 108-108.  show abstract

Stevens, K.N., Fredericksen, Z., Vachon, C.M., Wang, X., Margolin, S., Lindblom, A., Nevanlinna, H., Greco, D., Aittomäki, K., Blomqvist, C., et al. (2012). 19p13 1 Is a Triple-Negative-Specific Breast Cancer Susceptibility Locus. Cancer res, Vol.72 (7), pp. 1795-1803.  show abstract

Brennan, K., Garcia-Closas, M., Orr, N., Fletcher, O., Jones, M., Ashworth, A., Swerdlow, A., Thorne, H., KConFab Investigators, , Riboli, E., et al. (2012). Intragenic ATM methylation in peripheral blood DNA as a biomarker of breast cancer risk. Cancer res, Vol.72 (9), pp. 2304-2313.  show abstract

Swerdlow, A.J., Cooke, R., Bates, A., Cunningham, D., Falk, S.J., Gilson, D., Hancock, B.W., Harris, S.J., Horwich, A., Hoskin, P.J., et al. (2012). Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin's lymphoma in England and Wales: a National Cohort Study. J clin oncol, Vol.30 (22), pp. 2745-2752.  show abstract

Lin, J.C., Vecchia, P., Matthes, R., Feychting, M., Green, A., Jokela, K., Lin, J., Schulmeister, K., Sienkiewicz, Z., Peralta, A., et al. (2012). ICNIRP STATEMENT-HEALTH ISSUES ASSOCIATED WITH MILLIMETER WAVE WHOLE BODY IMAGING TECHNOLOGY. Health physics, Vol.102 (1), pp. 81-82.

Lambrechts, D., Truong, T., Justenhoven, C., Humphreys, M.K., Wang, J., Hopper, J.L., Dite, G.S., Apicella, C., Southey, M.C., Schmidt, M.K., et al. (2012). 11q13 is a susceptibility locus for hormone receptor positive breast cancer. Human mutation, Vol.33 (7), pp. 1123-1132.

Orr, N., Lemnrau, A., Cooke, R., Fletcher, O., Tomczyk, K., Jones, M., Johnson, N., Lord, C.J., Mitsopoulos, C., Zvelebil, M., et al. (2012). Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk. Nat genet, Vol.44 (11), pp. 1182-1184.  show abstract

Jones, M.E., van Leeuwen, F.E., Hoogendoorn, W.E., Mourits, M.J., Hollema, H., van Boven, H., Press, M.F., Bernstein, L. & Swerdlow, A.J. (2012). Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: pooled results from three countries. Breast cancer res, Vol.14 (3), p. R91.  show abstract

Rajaraman, P., Melin, B.S., Wang, Z., McKean-Cowdin, R., Michaud, D.S., Wang, S.S., Bondy, M., Houlston, R., Jenkins, R.B., Wrensch, M., et al. (2012). Genome-wide association study of glioma and meta-analysis. Human genetics, Vol.131 (12), pp. 1877-1888.

Morris, D.H., Jones, M.E., Schoemaker, M.J., McFadden, E., Ashworth, A. & Swerdlow, A.J. (2012). Body mass index, exercise, and other lifestyle factors in relation to age at natural menopause: analyses from the breakthrough generations study. Am j epidemiol, Vol.175 (10), pp. 998-1005.  show abstract

Brennan, K., Garcias-Closas, M., Orr, N., Fletcher, O., Jones, M., Ashworth, A., Swerdlow, A., Riboli, E., Vineis, P., Dorronsosro, M., et al. (2012). Abstract 4045: Intragenic ATM methylation in peripheral blood DNA as a biomarker of breast cancer risk. Molecular and cellular biology, .

Ross, G.M., Johnson, N., Orr, N., Walker, K., Gibson, L., Folkerd, E., Haynes, B., Palles, C., Coupland, B., Shoemaker, M., et al. (2012). Abstract P3-08-04: Impact of CYP3A variation on estrone levels and breast cancer risk. Poster session abstracts, .

Ma, Y.P., van Leeuwen, F.E., Cooke, R., Broeks, A., Enciso-Mora, V., Olver, B., Lloyd, A., Broderick, P., Russell, N.S., Janus, C., et al. (2012). FGFR2 genotype and risk of radiation-associated breast cancer in Hodgkin lymphoma. Blood, Vol.119 (4), pp. 1029-1031.  show abstract

Morris, D.H., Jones, M.E., Schoemaker, M.J., Ashworth, A. & Swerdlow, A.J. (2012). Familial concordance for height and its components: analyses from the Breakthrough Generations Study. Am j hum biol, Vol.24, pp. 22-27.  show abstract

Ghoussaini, M., Fletcher, O., Michailidou, K., Turnbull, C., Schmidt, M.K., Dicks, E., Dennis, J., Wang, Q., Humphreys, M.K., Luccarini, C., et al. (2012). Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat genet, Vol.44, pp. 312-318.  show abstract

Johnson, N., Walker, K., Gibson, L.J., Orr, N., Folkerd, E., Haynes, B., Palles, C., Coupland, B., Schoemaker, M., Jones, M., et al. (2012). CYP3A variation, premenopausal estrone levels, and breast cancer risk. J natl cancer inst, Vol.104, pp. 657-669.  show abstract

Hein, R., Maranian, M., Hopper, J.L., Kapuscinski, M.K., Southey, M.C., Park, D.J., Schmidt, M.K., Broeks, A., Hogervorst, F.B., Bueno-de-Mesquit, H.B., et al. (2012). Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC). Plos one, Vol.7 (8), p. e42380.  show abstract

Warren, H., Dudbridge, F., Fletcher, O., Orr, N., Johnson, N., Hopper, J.L., Apicella, C., Southey, M.C., Mahmoodi, M., Schmidt, M.K., et al. (2012). 9q31 2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium. Cancer epidemiol biomarkers prev, Vol.21, pp. 1783-1791.  show abstract

Olsen, C.M., Zens, M.S., Green, A.C., Stukel, T.A., Holman, C.D., Mack, T., Elwood, J.M., Holly, E.A., Sacerdote, C., Gallagher, R., et al. (2011). Biologic markers of sun exposure and melanoma risk in women: Pooled case-control analysis. Int j cancer, Vol.129 (3), pp. 713-723.  show abstract

Dobbins, S.E., Hosking, F.J., Shete, S., Armstrong, G., Swerdlow, A., Liu, Y., Yu, R., Lau, C., Schoemaker, M.J., Hepworth, S.J., et al. (2011). Allergy and glioma risk: test of association by genotype. Int j cancer, Vol.128 (7), pp. 1736-1740.  show abstract

Amirian, E.S., Scheurer, M.E., Liu, Y., Damelio, A.M., Houlston, R.S., Etzel, C.J., Shete, S.S., Swerdlow, A.J., Schoemaker, M.J., McKinney, P., et al. (2011). A Novel Approach to Exploring Potential Interactions among Single-Nucleotide Polymorphisms of Inflammation Genes in Gliomagenesis: An Exploratory Case-Only Study. Cancer epidemiol biomarkers prev, .  show abstract

Swerdlow, A.J., Higgins, C.D., Smith, P., Cunningham, D., Hancock, B.W., Horwich, A., Hoskin, P.J., Lister, T.A., Radford, J.A., Rohatiner, A.Z., et al. (2011). Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort study. J clin oncol, Vol.29 (31), pp. 4096-4104.  show abstract

Larjavaara, S., Schüz, J., Swerdlow, A., Feychting, M., Johansen, C., Lagorio, S., Tynes, T., Klaeboe, L., Tonjer, S.R., Blettner, M., et al. (2011). Location of gliomas in relation to mobile telephone use: a case-case and case-specular analysis. Am j epidemiol, Vol.174 (1), pp. 2-11.  show abstract

Auvinen, A., Larjavaara, S., Tynes, T., Schuz, J., Swerdlow, A., Feychting, M., Johansen, C. & Lagorio, S. (2011). MOBILE PHONE USE AND LOCATION OF GLIOMA: A CASE-CASE ANALYSIS. J epidemiol commun h, Vol.65, pp. A225-A225.

Orr, N., Cooke, R., Jones, M., Fletcher, O., Dudbridge, F., Chilcott-Burns, S., Tomczyk, K., Broderick, P., Houlston, R., Ashworth, A., et al. (2011). Genetic variants at chromosomes 2q35, 5p12, 6q25 1, 10q26 13, and 16q12 1 influence the risk of breast cancer in men. Plos genet, Vol.7 (9), p. e1002290.  show abstract

Cardis, E., Deltour, I., Vrijheid, M., Evrard, A.S., Moissonnier, M., Armstrong, B., Brown, J., Giles, G., Siemiatycki, J., Nadon, L., et al. (2011). Acoustic neuroma risk in relation to mobile telephone use: Results of the INTERPHONE international case-control study. Cancer epidemiol, Vol.35 (5), pp. 453-464.  show abstract

Saarinen, S., Aavikko, M., Aittomäki, K., Launonen, V., Lehtonen, R., Franssila, K., Lehtonen, H.J., Kaasinen, E., Broderick, P., Tarkkanen, J., et al. (2011). Exome sequencing reveals germline NPAT mutation as a candidate risk factor for Hodgkin lymphoma. Blood, .  show abstract

Sanson, M., Hosking, F.J., Shete, S., Zelenika, D., Dobbins, S.E., Ma, Y., Enciso-Mora, V., Idbaih, A., Delattre, J.Y., Hoang-Xuan, K., et al. (2011). Chromosome 7p11 2 (EGFR) variation influences glioma risk. Hum mol genet, Vol.20 (14), pp. 2897-2904.  show abstract

Moutsianas, L., Enciso-Mora, V., Ma, Y.P., Leslie, S., Dilthey, A., Broderick, P., Sherborne, A., Cooke, R., Ashworth, A., Swerdlow, A.J., et al. (2011). Multiple Hodgkin lymphoma-associated loci within the HLA region at chromosome 6p21 3. Blood, .  show abstract

Murray, A., Bennett, C.E., Perry, J.R., Weedon, M.N., Jacobs, P.A., Morris, D.H., Orr, N., Schoemaker, M.J., Jones, M., Ashworth, A., et al. (2011). Common genetic variants are significant risk factors for early menopause: results from the Breakthrough Generations Study. Hum mol genet, Vol.20, pp. 186-192.  show abstract

Morris, D.H., Jones, M.E., Schoemaker, M.J., Ashworth, A. & Swerdlow, A.J. (2011). Familial concordance for age at menarche: analyses from the Breakthrough Generations Study. Paediatr perinat epidemiol, Vol.25, pp. 306-311.  show abstract

Morris, D.H., Jones, M.E., Schoemaker, M.J., Ashworth, A. & Swerdlow, A.J. (2011). Familial concordance for age at natural menopause: results from the Breakthrough Generations Study. Menopause, Vol.18, pp. 956-961.  show abstract

Morris, D.H., Jones, M.E., Schoemaker, M.J., Ashworth, A. & Swerdlow, A.J. (2011). Secular trends in age at menarche in women in the UK born 1908-93: results from the Breakthrough Generations Study. Paediatr perinat epidemiol, Vol.25, pp. 394-400.  show abstract

Fletcher, O., Johnson, N., Orr, N., Hosking, F.J., Gibson, L.J., Walker, K., Zelenika, D., Gut, I., Heath, S., Palles, C., et al. (2011). Novel breast cancer susceptibility locus at 9q31 2: results of a genome-wide association study. J natl cancer inst, Vol.103, pp. 425-435.  show abstract

Swerdlow, A.J., Jones, M.E., Schoemaker, M.J., Hemming, J., Thomas, D., Williamson, J. & Ashworth, A. (2011). The Breakthrough Generations Study: design of a long-term UK cohort study to investigate breast cancer aetiology. Br j cancer, Vol.105, pp. 911-917.  show abstract

Dobbins, S.E., Broderick, P., Melin, B., Feychting, M., Johansen, C., Andersson, U., Brännström, T., Schramm, J., Olver, B., Lloyd, A., et al. (2011). Common variation at 10p12 31 near MLLT10 influences meningioma risk. Nat genet, Vol.43 (9), pp. 825-827.  show abstract

Figueroa, J.D., Garcia-Closas, M., Humphreys, M., Platte, R., Hopper, J.L., Southey, M.C., Apicella, C., Hammet, F., Schmidt, M.K., Broeks, A., et al. (2011). Associations of common variants at 1p11 2 and 14q24 1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum mol genet, Vol.20, pp. 4693-4706.  show abstract

Macsween, K.F., Higgins, C.D., McAulay, K.A., Williams, H., Harrison, N., Swerdlow, A.J. & Crawford, D.H. (2010). Infectious mononucleosis in university students in the United kingdom: evaluation of the clinical features and consequences of the disease. Clin infect dis, Vol.50 (5), pp. 699-706.  show abstract

Schoemaker, M.J., Robertson, L., Wigertz, A., Jones, M.E., Hosking, F.J., Feychting, M., Lönn, S., McKinney, P.A., Hepworth, S.J., Muir, K.R., et al. (2010). Interaction between 5 genetic variants and allergy in glioma risk. Am j epidemiol, Vol.171 (11), pp. 1165-1173.  show abstract

Broderick, P., Cunningham, D., Vijayakrishnan, J., Cooke, R., Ashworth, A., Swerdlow, A. & Houlston, R. (2010). IRF4 polymorphism rs872071 and risk of Hodgkin lymphoma. Brit j haematol, Vol.148 (3), pp. 413-415.  show abstract

Mudie, N.Y., Swerdlow, A.J., Gusev, B.I., Schoemaker, M.J., Pivina, L.M., Chsherbakova, S., Mansarina, A., Bauer, S., Jakovlev, Y. & Apsalikov, K.N., et al. (2010). Twinning in the offspring of parents with chronic radiation exposure from nuclear testing in Kazakhstan. Radiat res, Vol.173 (6), pp. 829-836.  show abstract

Cardis, E., Deltour, I., Vrijheid, M., Combalot, E., Moissonnier, M., Tardy, H., Armstrong, B., Giles, G., Brown, J., Siemiatycki, J., et al. (2010). Brain tumour risk in relation to mobile telephone use: results of the INTERPHONE international case-control study. Int j epidemiol, Vol.39 (3), pp. 675-694.  show abstract

(2010). ICNIRP STATEMENT—PROTECTION OF WORKERS AGAINST ULTRAVIOLET RADIATION. Health physics, Vol.99 (1), pp. 66-87.

Andersson, U., Schwartzbaum, J., Wiklund, F., Sjöström, S., Liu, Y., Tsavachidis, S., Ahlbom, A., Auvinen, A., Collatz-Laier, H., Feychting, M., et al. (2010). A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk. Acta oncol, Vol.49 (6), pp. 767-775.  show abstract

Auvinen, A., Lahkola, A., Feychting, M., Swerdlow, A.J., Johansen, C. & Tynes, T. (2010). Response to commentary: Meningioma and mobile phone use-a collaborative case-control study in five North European countries. Int j epidemiol, Vol.39 (4), pp. 1119-1119.

Schwartzbaum, J.A., Xiao, Y., Liu, Y., Tsavachidis, S., Berger, M.S., Bondy, M.L., Chang, J.S., Chang, S.M., Decker, P.A., Ding, B., et al. (2010). Inherited variation in immune genes and pathways and glioblastoma risk. Carcinogenesis, Vol.31 (10), pp. 1770-1777.  show abstract

Cooke, R., Laing, S. & Swerdlow, A.J. (2010). A case-control study of risk of leukaemia in relation to mobile phone use. British journal of cancer, Vol.103 (11), pp. 1729-1735.  show abstract  full text

Enciso-Mora, V., Broderick, P., Ma, Y., Jarrett, R.F., Hjalgrim, H., Hemminki, K., van den Berg, A., Olver, B., Lloyd, A., Dobbins, S.E., et al. (2010). A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16 1 (REL), 8q24 21 and 10p14 (GATA3). Nat genet, Vol.42 (12), pp. 1126-1130.  show abstract

Non-Ionizing, I.C. (2010). ICNIRP STATEMENT-GUIDELINES FOR LIMITING EXPOSURE TO TIME-VARYING ELECTRIC AND MAGNETIC FIELDS (1 HZ TO 100 KHZ). Health physics, Vol.99 (6), pp. 818-836.

Morris, D.H., Jones, M.E., Schoemaker, M.J., Ashworth, A. & Swerdlow, A.J. (2010). Determinants of age at menarche in the UK: analyses from the Breakthrough Generations Study. Br j cancer, Vol.103 (11), pp. 1760-1764.  show abstract

Silva, I.D., Higgins, C.D., Abramsky, T., Swanwick, M.A., Frazer, J., Whitaker, L.M., Blanshard, M.E., Bradshaw, J., Apps, J.M., Bishop, D.T., et al. (2009). Overseas sun exposure, nevus counts, and premature skin aging in young English women: a population-based survey. J invest dermatol, Vol.129 (1), pp. 50-59.  show abstract

Blanks, R.G., Moss, S.M., Addou, S., Coleman, D.A. & Swerdlow, A.J. (2009). Risk of cervical abnormality after age 50 in women with previously negative smears. Br j cancer, Vol.100 (11), pp. 1832-1836.  show abstract

(2009). GUIDELINES ON LIMITS OF EXPOSURE TO STATIC MAGNETIC FIELDS. Health physics, Vol.96 (4), pp. 504-514.

Schoemaker, M.J. & Swerdlow, A.J. (2009). Risk of pituitary tumors in cellular phone users: a case-control study. Epidemiology, Vol.20 (3), pp. 348-354.  show abstract

Schoemaker, M.J. & Swerdlow, A.J. (2009). Risk factors for pituitary tumors: a case-control study. Cancer epidemiol biomarkers prev, Vol.18 (5), pp. 1492-1500.  show abstract

Blanks, R.G., Moss, S.M., Coleman, D.A., Addou, S. & Swerdlow, A.J. (2009). The use of screening episodes linked to CIN3 and invasive cancer registrations to study outcomes from the NHS Cervical Screening Programme. Cytopathology, Vol.20 (3), pp. 154-160.  show abstract

Chang, Y.M., Barrett, J.H., Bishop, D.T., Armstrong, B.K., Bataille, V., Bergman, W., Berwick, M., Bracci, P.M., Elwood, J.M., Ernstoff, M.S., et al. (2009). Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls. Int j epidemiol, Vol.38 (3), pp. 814-830.  show abstract

Shete, S., Hosking, F.J., Robertson, L.B., Dobbins, S.E., Sanson, M., Malmer, B., Simon, M., Marie, Y., Boisselier, B., Delattre, J.Y., et al. (2009). Genome-wide association study identifies five susceptibility loci for glioma. Nature genetics, Vol.41 (8), pp. 899-904.  show abstract

Ahlbom, A., Feychting, M., Green, A., Kheifets, L., Savitz, D.A., Swerdlow, A.J. & ICNIRP (International Commission for Non-Ionizing Radiation Protection) Standing Committee on Epidemiology, (2009). Epidemiologic evidence on mobile phones and tumor risk: a review. Epidemiology, Vol.20 (5), pp. 639-652.  show abstract

(2009). AMENDMENT TO THE ICNIRP “STATEMENT ON MEDICAL MAGNETIC RESONANCE (MR) PROCEDURES: PROTECTION OF PATIENTS”. Health physics, Vol.97 (3), pp. 259-261.

(2009). ICNIRP STATEMENT ON THE “GUIDELINES FOR LIMITING EXPOSURE TO TIME-VARYING ELECTRIC, MAGNETIC, AND ELECTROMAGNETIC FIELDS (UP TO 300 GHz)”. Health physics, Vol.97 (3), pp. 257-258.

Randerson-Moor, J.A., Taylor, J.C., Elliott, F., Chang, Y.M., Beswick, S., Kukalizch, K., Affleck, P., Leake, S., Haynes, S., Karpavicius, B., et al. (2009). Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data. Eur j cancer, Vol.45 (18), pp. 3271-3281.  show abstract

Chang, Y.M., Newton-Bishop, J.A., Bishop, D.T., Armstrong, B.K., Bataille, V., Bergman, W., Berwick, M., Bracci, P.M., Elwood, J.M., Ernstoff, M.S., et al. (2009). A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes. Int j cancer, Vol.124 (2), pp. 420-428.  show abstract

Olsen, C.M., Zens, M.S., Stukel, T.A., Sacerdote, C., Chang, Y.M., Armstrong, B.K., Bataille, V., Berwick, M., Elwood, J.M., Holly, E.A., et al. (2009). Nevus density and melanoma risk in women: a pooled analysis to test the divergent pathway hypothesis. Int j cancer, Vol.124 (4), pp. 937-944.  show abstract

Andersson, U., Osterman, P., Sjöström, S., Johansen, C., Henriksson, R., Brännström, T., Broholm, H., Christensen, H.C., Ahlbom, A., Auvinen, A., et al. (2009). MNS16A minisatellite genotypes in relation to risk of glioma and meningioma and to glioblastoma outcome. Int j cancer, Vol.125 (4), pp. 968-972.  show abstract

Bethke, L., Sullivan, K., Webb, E., Murray, A., Schoemaker, M., Auvinen, A., Kiuru, A., Salminen, T., Johansen, C., Christensen, H.C., et al. (2009). CASP8 D302H and meningioma risk: an analysis of five case-control series. Cancer lett, Vol.273 (2), pp. 312-315.  show abstract

Olsen, C.M., Green, A.C., Zens, M.S., Stukel, T.A., Bataille, V., Berwick, M., Elwood, J.M., Gallagher, R., Holly, E.A., Kirkpatrick, C., et al. (2008). Anthropometric factors and risk of melanoma in women: a pooled analysis. Int j cancer, Vol.122 (5), pp. 1100-1108.  show abstract

Swerdlow, A.J., Schoemaker, M.J., Higgins, C.D., Wright, A.F., Jacobs, P.A. & UK Clinical Cytogenetics Group, (2008). Mortality risks in patients with constitutional autosomal chromosome deletions in Britain: a cohort study. Hum genet, Vol.123 (2), pp. 215-224.  show abstract

Schoemaker, M.J., Swerdlow, A.J., Higgins, C.D., Wright, A.F., Jacobs, P.A. & UK Clinical Cytogenetics Group, (2008). Cancer incidence in women with Turner syndrome in Great Britain: a national cohort study. Lancet oncol, Vol.9 (3), pp. 239-246.  show abstract

Bethke, L., Sullivan, K., Webb, E., Murray, A., Schoemaker, M., Auvinen, A., Kiuru, A., Salminen, T., Johansen, C., Christensen, H.C., et al. (2008). The common D302H variant of CASP8 is associated with risk of glioma. Cancer epidemiol biomarkers prev, Vol.17 (4), pp. 987-989.  show abstract

Bethke, L., Webb, E., Murray, A., Schoemaker, M., Feychting, M., Lönn, S., Ahlbom, A., Malmer, B., Henriksson, R., Auvinen, A., et al. (2008). Functional polymorphisms in folate metabolism genes influence the risk of meningioma and glioma. Cancer epidemiol biomarkers prev, Vol.17 (5), pp. 1195-1202.  show abstract

Kiuru, A., Lindholm, C., Heinävaara, S., Ilus, T., Jokinen, P., Haapasalo, H., Salminen, T., Christensen, H.C., Feychting, M., Johansen, C., et al. (2008). XRCC1 and XRCC3 variants and risk of glioma and meningioma. J neurooncol, Vol.88 (2), pp. 135-142.  show abstract

Wigertz, A., Lönn, S., Hall, P., Auvinen, A., Christensen, H.C., Johansen, C., Klaeboe, L., Salminen, T., Schoemaker, M.J., Swerdlow, A.J., et al. (2008). Reproductive factors and risk of meningioma and glioma. Cancer epidemiol biomarkers prev, Vol.17 (10), pp. 2663-2670.  show abstract

Lahkola, A., Salminen, T., Raitanen, J., Heinävaara, S., Schoemaker, M.J., Christensen, H.C., Feychting, M., Johansen, C., Klaeboe, L., Lönn, S., et al. (2008). Meningioma and mobile phone use--a collaborative case-control study in five North European countries. Int j epidemiol, Vol.37 (6), pp. 1304-1313.  show abstract

Schoemaker, M.J., Swerdlow, A.J., Higgins, C.D., Wright, A.F., Jacobs, P.A. & United Kingdom Clinical Cytogenetics Group, (2008). Mortality in women with turner syndrome in Great Britain: a national cohort study. J clin endocrinol metab, Vol.93 (12), pp. 4735-4742.  show abstract

Bethke, L., Webb, E., Murray, A., Schoemaker, M., Johansen, C., Christensen, H.C., Muir, K., McKinney, P., Hepworth, S., Dimitropoulou, P., et al. (2008). Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma. Hum mol genet, Vol.17 (6), pp. 800-805.  show abstract

Swerdlow, A.J., Schoemaker, M.J., Higgins, C.D., Wright, A.F. & Jacobs, P.A. (2008). Cancer risk in patients with constitutional chromosome deletions: a nationwide British cohort study. Br j cancer, Vol.98 (12), pp. 1929-1933.  show abstract

Bethke, L., Murray, A., Webb, E., Schoemaker, M., Muir, K., McKinney, P., Hepworth, S., Dimitropoulou, P., Lophatananon, A., Feychting, M., et al. (2008). Comprehensive analysis of DNA repair gene variants and risk of meningioma. J natl cancer inst, Vol.100 (4), pp. 270-276.  show abstract

Schoemaker, M.J., Swerdlow, A.J., Auvinen, A., Christensen, H.C., Feychting, M., Johansen, C., Klaeboe, L., Lönn, S., Salminen, T. & Tynes, T., et al. (2007). Medical history, cigarette smoking and risk of acoustic neuroma: an international case-control study. Int j cancer, Vol.120 (1), pp. 103-110.  show abstract

Schoemaker, M.J., Swerdlow, A.J., Hepworth, S.J., van Tongeren, M., Muir, K.R. & McKinney, P.A. (2007). History of allergic disease and risk of meningioma. Am j epidemiol, Vol.165 (5), pp. 477-485.  show abstract

Schwartzbaum, J.A., Ahlbom, A., Lönn, S., Warholm, M., Rannug, A., Auvinen, A., Christensen, H.C., Henriksson, R., Johansen, C., Lindholm, C., et al. (2007). An international case-control study of glutathione transferase and functionally related polymorphisms and risk of primary adult brain tumors. Cancer epidemiol biomarkers prev, Vol.16 (3), pp. 559-565.  show abstract

Malmer, B.S., Feychting, M., Lönn, S., Lindström, S., Grönberg, H., Ahlbom, A., Schwartzbaum, J., Auvinen, A., Collatz-Christensen, H., Johansen, C., et al. (2007). Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma. J neurooncol, Vol.82 (3), pp. 229-237.  show abstract

Jones, M.E., Folkerd, E.J., Doody, D.A., Iqbal, J., Dowsett, M., Ashworth, A. & Swerdlow, A.J. (2007). Effect of delays in processing blood samples on measured endogenous plasma sex hormone levels in women. Cancer epidemiol biomarkers prev, Vol.16 (6), pp. 1136-1139.  show abstract

Swerdlow, A.J., Higgins, C.D., Smith, P., Cunningham, D., Hancock, B.W., Horwich, A., Hoskin, P.J., Lister, A., Radford, J.A., Rohatiner, A.Z., et al. (2007). Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. J natl cancer inst, Vol.99 (3), pp. 206-214.  show abstract

Higgins, C.D., Swerdlow, A.J., Schoemaker, M.J., Wright, A.F., Jacobs, P.A. & UK Clinical Cytogenetics Group, (2007). Mortality and cancer incidence in males with Y polysomy in Britain: a cohort study. Hum genet, Vol.121 (6), pp. 691-696.  show abstract

Blanks, R.G., Moss, S.M., Coleman, D.A. & Swerdlow, A.J. (2007). An examination of the role of opportunistic smear taking in the NHS cervical screening programme using data from the CSEU cervical screening cohort study. Bjog, Vol.114 (11), pp. 1408-1413.  show abstract

Mudie, N.Y., Gusev, B.I., Pivina, L.M., Schoemaker, M.J., Rijinkova, O.N., Apsalikov, K.N. & Swerdlow, A.J. (2007). Sex ratio in the offspring of parents with chronic radiation exposure from nuclear testing in Kazakhstan. Radiat res, Vol.168 (5), pp. 600-607.  show abstract

Schwartzbaum, J.A., Ahlbom, A., Lönn, S., Malmer, B., Wigertz, A., Auvinen, A., Brookes, A.J., Collatz Christensen, H., Henriksson, R., Johansen, C., et al. (2007). An international case-control study of interleukin-4Ralpha, interleukin-13, and cyclooxygenase-2 polymorphisms and glioblastoma risk. Cancer epidemiol biomarkers prev, Vol.16 (11), pp. 2448-2454.  show abstract

Swerdlow, A.J. & Jones, M.E. (2007). Ovarian cancer risk in premenopausal and perimenopausal women treated with Tamoxifen: a case-control study. Br j cancer, Vol.96 (5), pp. 850-855.  show abstract

Higgins, C.D., Swerdlow, A.J., Macsween, K.F., Harrison, N., Williams, H., McAulay, K., Thomas, R., Reid, S., Conacher, M., Britton, K., et al. (2007). A study of risk factors for acquisition of Epstein-Barr virus and its subtypes. J infect dis, Vol.195 (4), pp. 474-482.  show abstract

Lahkola, A., Auvinen, A., Raitanen, J., Schoemaker, M.J., Christensen, H.C., Feychting, M., Johansen, C., Klaeboe, L., Lönn, S., Swerdlow, A.J., et al. (2007). Mobile phone use and risk of glioma in 5 North European countries. Int j cancer, Vol.120 (8), pp. 1769-1775.  show abstract

Haque, T., Wilkie, G.M., Jones, M.M., Higgins, C.D., Urquhart, G., Wingate, P., Burns, D., McAulay, K., Turner, M., Bellamy, C., et al. (2007). Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial. Blood, Vol.110 (4), pp. 1123-1131.  show abstract

Wigertz, A., Lönn, S., Schwartzbaum, J., Hall, P., Auvinen, A., Christensen, H.C., Johansen, C., Klaeboe, L., Salminen, T., Schoemaker, M.J., et al. (2007). Allergic conditions and brain tumor risk. Am j epidemiol, Vol.166 (8), pp. 941-950.  show abstract

Cardis, E., Richardson, L., Deltour, I., Armstrong, B., Feychting, M., Johansen, C., Kilkenny, M., McKinney, P., Modan, B., Sadetzki, S., et al. (2007). The INTERPHONE study: design, epidemiological methods, and description of the study population. Eur j epidemiol, Vol.22 (9), pp. 647-664.  show abstract

Mudie, N.Y., Swerdlow, A.J., Higgins, C.D., Smith, P., Qiao, Z., Hancock, B.W., Hoskin, P.J. & Linch, D.C. (2006). Risk of second malignancy after non-Hodgkin's lymphoma: a British Cohort Study. J clin oncol, Vol.24 (10), pp. 1568-1574.  show abstract

Crawford, D.H., Macsween, K.F., Higgins, C.D., Thomas, R., McAulay, K., Williams, H., Harrison, N., Reid, S., Conacher, M., Douglas, J., et al. (2006). A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis. Clin infect dis, Vol.43 (3), pp. 276-282.  show abstract

Schoemaker, M.J., Swerdlow, A.J., Hepworth, S.J., McKinney, P.A., van Tongeren, M. & Muir, K.R. (2006). History of allergies and risk of glioma in adults. Int j cancer, Vol.119 (9), pp. 2165-2172.  show abstract

Karagas, M.R., Zens, M.S., Stukel, T.A., Swerdlow, A.J., Rosso, S., Osterlind, A., Mack, T., Kirkpatrick, C., Holly, E.A., Green, A., et al. (2006). Pregnancy history and incidence of melanoma in women: a pooled analysis. Cancer causes control, Vol.17 (1), pp. 11-19.  show abstract

Schoemaker, M.J., Swerdlow, A.J., Auvinen, A., Cardis, E., Feychting, M., Johansen, C., McKinney, P.A. & Tynes, T. (2006). Reply: Mobile phone use and acoustic neuroma in five North European countries. Brit j cancer, Vol.94 (9), pp. 1352-1353.

Thomas, R., Macsween, K.F., McAulay, K., Clutterbuck, D., Anderson, R., Reid, S., Higgins, C.D., Swerdlow, A.J., Harrison, N., Williams, H., et al. (2006). Evidence of shared Epstein-Barr viral isolates between sexual partners, and low level EBV in genital secretions. J med virol, Vol.78 (9), pp. 1204-1209.  show abstract

Swerdlow, A.J. (2006). Does growth hormone therapy increase the risk of cancer?. Nat clin pract endocrinol metab, Vol.2 (10), pp. 530-531.

Hepworth, S.J., Schoemaker, M.J., Muir, K.R., Swerdlow, A.J., van Tongeren, M.J. & McKinney, P.A. (2006). Mobile phone use and risk of glioma in adults: case-control study. Bmj, Vol.332 (7546), pp. 883-887.  show abstract

Crawford, D.H., Macsween, K.F., Higgins, C.D., Thomas, R., McAulay, K., Williams, H., Harrison, N., Reid, S., Conacher, M., Douglas, J., et al. (2006). A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis (vol 43, pg 276, 2006). Clin infect dis, Vol.43 (6), pp. 805-805.

Swerdlow, A.J., Jones, M.E. & British Tamoxifen Second Cancer Study Group, (2005). Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study. J natl cancer inst, Vol.97 (5), pp. 375-384.  show abstract

Schoemaker, M.J., Swerdlow, A.J., Ahlbom, A., Auvinen, A., Blaasaas, K.G., Cardis, E., Christensen, H.C., Feychting, M., Hepworth, S.J., Johansen, C., et al. (2005). Mobile phone use and risk of acoustic neuroma: results of the Interphone case-control study in five North European countries. Br j cancer, Vol.93 (7), pp. 842-848.  show abstract

Silva, I.D., Higgins, C., Swerdlow, A.J., Laing, S.P., Slater, S.D., Pearson, D.W. & Morris, A.D. (2005). Birthweight and other pregnancy outcomes in a cohort of women with pre-gestational insulin-treated diabetes mellitus, Scotland, 1979-95. Diabet med, Vol.22 (4), pp. 440-447.  show abstract

Williams, H., McAulay, K., Macsween, K.F., Gallacher, N.J., Higgins, C.D., Harrison, N., Swerdlow, A.J. & Crawford, D.H. (2005). The immune response to primary EBV infection: a role for natural killer cells. Br j haematol, Vol.129 (2), pp. 266-274.  show abstract

Jackson, S., Harland, M., Turner, F., Taylor, C., Chambers, P.A., Randerson-Moor, J., Swerdlow, A.J., dos Santos Silva, I., Beswick, S., Bishop, D.T., et al. (2005). No Evidence for BRAF as a melanoma/nevus susceptibility gene. Cancer epidemiol biomarkers prev, Vol.14 (4), pp. 913-918.  show abstract

Swerdlow, A.J., Laing, S.P., Qiao, Z., Slater, S.D., Burden, A.C., Botha, J.L., Waugh, N.R., Morris, A.D., Gatling, W., Gale, E.A., et al. (2005). Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br j cancer, Vol.92 (11), pp. 2070-2075.  show abstract

Laing, S.P., Jones, M.E., Swerdlow, A.J., Burden, A.C. & Gatling, W. (2005). Psychosocial and socioeconomic risk factors for premature death in young people with type 1 diabetes. Diabetes care, Vol.28 (7), pp. 1618-1623.  show abstract

Swerdlow, A.J., Schoemaker, M.J., Higgins, C.D., Wright, A.F. & Jacobs, P.A. (2005). Mortality and cancer incidence in women with extra X chromosomes: a cohort study in Britain. Hum genet, Vol.118 (2), pp. 255-260.  show abstract

Swerdlow, A.J., Higgins, C.D., Schoemaker, M.J., Wright, A.F., Jacobs, P.A. & United Kingdom Clinical Cytogenetics Group, (2005). Mortality in patients with Klinefelter syndrome in Britain: a cohort study. J clin endocrinol metab, Vol.90 (12), pp. 6516-6522.  show abstract

Swerdlow, A.J., Schoemaker, M.J., Higgins, C.D., Wright, A.F., Jacobs, P.A. & UK Clinical Cytogenetics Group, (2005). Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study. J natl cancer inst, Vol.97 (16), pp. 1204-1210.  show abstract

Williams, H., Macsween, K., McAulay, K., Higgins, C., Harrison, N., Swerdlow, A., Britton, K. & Crawford, D. (2004). Analysis of immune activation and clinical events in acute infectious mononucleosis. J infect dis, Vol.190 (1), pp. 63-71.  show abstract

Bertram, C.G., Gaut, R.M., Barrett, J.H., Randerson-Moor, J., Whitaker, L., Turner, F., Bataille, V., dos Santos Silva, I., Swerdlow, A.J., Bishop, D.T., et al. (2004). An assessment of a variant of the DNA repair gene XRCC3 as a possible nevus or melanoma susceptibility genotype. J invest dermatol, Vol.122 (2), pp. 429-432.  show abstract

Swerdlow, A.J., Laing, S.P., Dos Santos Silva, I., Slater, S.D., Burden, A.C., Botha, J.L., Waugh, N.R., Morris, A.D., Gatling, W., Bingley, P.J., et al. (2004). Mortality of South Asian patients with insulin-treated diabetes mellitus in the United Kingdom: a cohort study. Diabet med, Vol.21 (8), pp. 845-851.  show abstract

McKinlay, A.F., Bernhardt, J.H., Ahlbom, A., Cesarini, J.P., de Gruijl, F.R., Hietanen, M., Owen, R., Sliney, D.H., Soderberg, P., Swerdlow, A.J., et al. (2004). Guidelines on limits of exposure to ultraviolet radiation of wavelengths between 180 nm and 400 nm (incoherent optical radiation). Health phys, Vol.87 (2), pp. 171-186.

Randerson-Moor, J.A., Gaut, R., Turner, F., Whitaker, L., Barrett, J.H., Silva, I.D., Swerdlow, A.J., Bishop, D.T. & Bishop, J.A. (2004). The relationship between the epidermal growth factor (EGF) 5 ' UTR variant A61G and melanoma/nevus susceptibility. J invest dermatol, Vol.123 (4), pp. 755-759.  show abstract

Ahlbom, A., Green, A., Kheifets, L., Savitz, D. & Swerdlow, A. (2004). Epidemiology of health effects of radiofrequency exposure. Environ health persp, Vol.112 (17), pp. 1741-1754.  show abstract

Horwich, A. & Swerdlow, A.J. (2004). Second primary breast cancer after Hodgkin's disease. Br j cancer, Vol.90 (2), pp. 294-298.  show abstract

McCormack, V.A., dos Santos Silva, I., De Stavola, B.L., Perry, N., Vinnicombe, S., Swerdlow, A.J., Hardy, R. & Kuh, D. (2003). Life-course body size and perimenopausal mammographic parenchymal patterns in the MRC 1946 British birth cohort. Br j cancer, Vol.89 (5), pp. 852-859.  show abstract

Laing, S.P., Swerdlow, A.J., Carpenter, L.M., Slater, S.D., Burden, A.C., Botha, J.L., Morris, A.D., Waugh, N.R., Gatling, W., Gale, E.A., et al. (2003). Mortality from cerebrovascular disease in a cohort of 23 000 patients with insulin-treated diabetes. Stroke, Vol.34 (2), pp. 418-421.  show abstract

dos Santos Silva, I., Malveiro, F., Jones, M.E. & Swerdlow, A.J. (2003). Mortality after radiological investigation with radioactive Thorotrast: a follow-up study of up to fifty years in Portugal. Radiat res, Vol.159 (4), pp. 521-534.  show abstract

Swerdlow, A.J. (2003). Epidemiology of Hodgkin's disease and non-Hodgkin's lymphoma. Eur j nucl med mol imaging, Vol.30 Suppl 1, pp. S3-12.  show abstract

Laing, S.P., Swerdlow, A.J., Slater, S.D., Burden, A.C., Morris, A., Waugh, N.R., Gatling, W., Bingley, P.J. & Patterson, C.C. (2003). Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia, Vol.46 (6), pp. 760-765.  show abstract

Swerdlow, A.J., Higgins, C.D., Adlard, P., Jones, M.E. & Preece, M.A. (2003). Creutzfeldt-Jakob disease in United Kingdom patients treated with human pituitary growth hormone. Neurology, Vol.61 (6), pp. 783-791.  show abstract

Higgins, C.D., Swerdlow, A.J., Smith, J.D., Hunt, B.J., Thomas, J.A., Burke, M.M., Crawford, D.H. & Yacoub, M.H. (2003). Risk of lymphoid neoplasia after cardiothoracic transplantation: the influence of underlying disease and human leukocyte antigen type and matching. Transplantation, Vol.75 (10), pp. 1698-1703.  show abstract

Karagas, M.R., Stukel, T.A., Dykes, J., Miglionico, J., Greene, M.A., Carey, M., Armstrong, B., Elwood, J.M., Gallagher, R.P., Green, A., et al. (2002). A pooled analysis of 10 case-control studies of melanoma and oral contraceptive use. Br j cancer, Vol.86 (7), pp. 1085-1092.  show abstract

Doyle, P., Maconochie, N., Beral, V., Swerdlow, A.J. & Tan, S.L. (2002). Cancer incidence following treatment for infertility at a clinic in the UK. Hum reprod, Vol.17 (8), pp. 2209-2213.  show abstract

Haque, T., Wilkie, G.M., Taylor, C., Amlot, P.L., Murad, P., Iley, A., Dombagoda, D., Britton, K.M., Swerdlow, A.J. & Crawford, D.H., et al. (2002). Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells. Lancet, Vol.360 (9331), pp. 436-442.  show abstract

Bertram, C.G., Gaut, R.M., Barrett, J.H., Pinney, E., Whitaker, L., Turner, F., Bataille, V., Silvaj, I.D., Swerdlow, A.J., Bishop, D.T., et al. (2002). An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility allele. J invest dermatol, Vol.119 (4), pp. 961-965.  show abstract

Crawford, D.H., Swerdlow, A.J., Higgins, C., McAulay, K., Harrison, N., Williams, H., Britton, K. & Macsween, K.F. (2002). Sexual history and Epstein-Barr virus infection. J infect dis, Vol.186 (6), pp. 731-736.  show abstract

Swerdlow, A.J., De Stavola, B.L., Floderus, B., Holm, N.V., Kaprio, J., Verkasalo, P.K. & Mack, T. (2002). Risk factors for breast cancer at young ages in twins: an international population-based study. J natl cancer inst, Vol.94 (16), pp. 1238-1246.  show abstract

Swerdlow, A.J., Higgins, C.D., Adlard, P. & Preece, M.A. (2002). Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study. Lancet, Vol.360 (9329), pp. 273-277.  show abstract

Higgins, C.D., dos-Santos-Silva, I., Stiller, C.A. & Swerdlow, A.J. (2001). Season of birth and diagnosis of children with leukaemia: an analysis of over 15 000 UK cases occurring from 1953-95. Br j cancer, Vol.84 (3), pp. 406-412.  show abstract

Swerdlow, A.J., Elsby, B. & Qiao, Z. (2001). Cancer incidence in the Falkland Islands. Br j cancer, Vol.85 (9), pp. 1332-1334.  show abstract

Hermon, C., Alberman, E., Beral, V. & Swerdlow, A.J. (2001). Mortality and cancer incidence in persons with Down's syndrome, their parents and siblings. Ann hum genet, Vol.65 (Pt 2), pp. 167-176.  show abstract

Swerdlow, A.J., Hermon, C., Jacobs, P.A., Alberman, E., Beral, V., Daker, M., Fordyce, A. & Youings, S. (2001). Mortality and cancer incidence in persons with numerical sex chromosome abnormalities: a cohort study. Ann hum genet, Vol.65 (Pt 2), pp. 177-188.  show abstract

Ahlbom, A., Cardis, E., Green, A., Linet, M., Savitz, D., Swerdlow, A. & ICNIRP Standing Comm Epidemiology, (2001). Review of the epidemiologic literature on EMF and health. Environ health persp, Vol.109, pp. 911-933.  show abstract

Ahlbom, I.C., Cardis, E., Green, A., Linet, M., Savitz, D. & Swerdlow, A. (2001). Review of the epidemiologic literature on EMF and Health. Environmental health perspectives, Vol.109 (suppl 6), pp. 911-933.

Swerdlow, A.J., Schoemaker, M.J., Allerton, R., Horwich, A., Barber, J.A., Cunningham, D., Lister, T.A., Rohatiner, A.Z., Vaughan Hudson, G., Williams, M.V., et al. (2001). Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment. J clin oncol, Vol.19 (6), pp. 1610-1618.  show abstract

Swerdlow, A.J., Reddingius, R.E., Higgins, C.D., Spoudeas, H.A., Phipps, K., Qiao, Z., Ryder, W.D., Brada, M., Hayward, R.D., Brook, C.G., et al. (2000). Growth Hormone Treatment of Children with Brain Tumors and Risk of Tumor Recurrence1. The journal of clinical endocrinology & metabolism, Vol.85 (12), pp. 4444-4449.

Swerdlow, A.J., Barber, J.A., Hudson, G.V., Cunningham, D., Gupta, R.K., Hancock, B.W., Horwich, A., Lister, T.A. & Linch, D.C. (2000). Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J clin oncol, Vol.18 (3), pp. 498-509.  show abstract

Roy, P., Vaughan Hudson, G., Vaughan Hudson, B., Esteve, J. & Swerdlow, A.J. (2000). Long-term survival in Hodgkin's disease patients A comparison of relative survival in patients in trials and those recorded in population-based cancer registries. Eur j cancer, Vol.36 (3), pp. 384-389.  show abstract

Schoemaker, M.J., Barreto, S.M., Swerdlow, A.J., Higgins, C.D. & Carpenter, R.G. (2000). Non-fatal work related injuries in a cohort of Brazilian steelworkers. Occup environ med, Vol.57 (8), pp. 555-562.  show abstract

Stavola, B.L., Hardy, R., Kuh, D., Silva, I.S., Wadsworth, M. & Swerdlow, A.J. (2000). Birthweight, childhood growth and risk of breast cancer in a British cohort. Br j cancer, Vol.83 (7), pp. 964-968.  show abstract

Swerdlow, A.J., Reddingius, R.E., Higgins, C.D., Spoudeas, H.A., Phipps, K., Qiao, Z., Ryder, W.D., Brada, M., Hayward, R.D., Brook, C.G., et al. (2000). Growth hormone treatment of children with brain tumors and risk of tumor recurrence. J clin endocrinol metab, Vol.85 (12), pp. 4444-4449.  show abstract

Swerdlow, A.J. (2000). Design and interpretation of studies of the risk of cancer and other long-term morbidity and mortality after growth hormone treatment. Growth horm igf res, Vol.10 (6), pp. 318-323.

Barreto, S.M., Swerdlow, A.J., Schoemaker, M.J. & Smith, P.G. (2000). Predictors of first nonfatal occupational injury following employment in a Brazilian steelworks. Scand j work environ health, Vol.26 (6), pp. 523-528.  show abstract

Swerdlow, A.J., Higgins, C.D., Hunt, B.J., Thomas, J.A., Burke, M.M., Crawford, D.H. & Yacoub, M.H. (2000). Risk of lymphoid neoplasia after cardiothoracic transplantation a cohort study of the relation to Epstein-Barr virus. Transplantation, Vol.69 (5), pp. 897-904.  show abstract

Swerdlow, A.J., De Stavola, B.L., Swanwick, M.A., Mangtani, P. & Maconochie, N.E. (1999). Risk factors for testicular cancer: a case-control study in twins. Br j cancer, Vol.80 (7), pp. 1098-1102.  show abstract

Laing, S.P., Swerdlow, A.J., Slater, S.D., Botha, J.L., Burden, A.C., Waugh, N.R., Smith, A.W., Hill, R.D., Bingley, P.J., Patterson, C.C., et al. (1999). The British Diabetic Association Cohort Study, I: all-cause mortality in patients with insulin-treated diabetes mellitus. Diabet med, Vol.16 (6), pp. 459-465.  show abstract

Laing, S.P., Swerdlow, A.J., Slater, S.D., Botha, J.L., Burden, A.C., Waugh, N.R., Smith, A.W., Hill, R.D., Bingley, P.J., Patterson, C.C., et al. (1999). The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet med, Vol.16 (6), pp. 466-471.  show abstract

dos Santos Silva, I., Jones, M., Malveiro, F. & Swerdlow, A. (1999). Mortality in the Portuguese thorotrast study. Radiat res, Vol.152 (6 Suppl), pp. S88-S92.  show abstract

dos Santos Silva, I., Swerdlow, A.J., Stiller, C.A. & Reid, A. (1999). Incidence of testicular germ-cell malignancies in England and Wales: trends in children compared with adults. Int j cancer, Vol.83 (5), pp. 630-634.  show abstract

Graham, A., Fuller, A., Murphy, M., Jones, M., Forman, D. & Swerdlow, A.J. (1999). Maternal and child constitutional factors and the frequency of melanocytic naevi in children. Paediatr perinat epidemiol, Vol.13, pp. 316-324.  show abstract

dos Santos Silva, I., Jones, M., Malveiro, F. & Swerdlow, A. (1999). Mortality in the Portuguese thorotrast study. Radiat res, Vol.152, pp. S88-S92.  show abstract

Swerdlow, A.J. & Weinstock, M.A. (1998). Do tanning lamps cause melanoma? An epidemiologic assessment. J am acad dermatol, Vol.38 (1), pp. 89-98.  show abstract

Horwich, A., Swerdlow, A.J., Barber, J.A., Hudson, G.V., Gupta, R.K., Linch, D., Cunningham, D. & Listor, T.A. (1998). Analysis of second malignancy after Hodgkin's disease. Brit j cancer, Vol.78, pp. 5-5.

Bataille, V., Grulich, A., Sasieni, P., Swerdlow, A., Newton Bishop, J., McCarthy, W., Hersey, P. & Cuzick, J. (1998). The association between naevi and melanoma in populations with different levels of sun exposure: a joint case-control study of melanoma in the UK and Australia. British journal of cancer, Vol.77 (3), pp. 505-510.

Swerdlow, A.J., Higgins, C.D., Brook, C.G., Dunger, D.B., Hindmarsh, P.C., Price, D.A. & Savage, M.O. (1998). Mortality in patients with congenital adrenal hyperplasia: a cohort study. J pediatr, Vol.133 (4), pp. 516-520.  show abstract

Swerdlow, A.J., De Stavola, B.L., Swanwick, M.A. & Maconochie, N.E. (1998). Twinning, cancer, and genetics - Reply. Lancet, Vol.351 (9106), pp. 910-910.

Bataille, V., Sasieni, P., Grulich, A., Swerdlow, A., McCarthy, W., Hersey, P., Newton Bishop, J.A. & Cuzick, J. (1998). Solar keratoses: A risk factor for melanoma but negative association with melanocytic naevi. International journal of cancer, Vol.78 (1), pp. 8-12.

Swerdlow, A.J., dos Santos Silva, I., Reid, A., Qiao, Z., Brewster, D.H. & Arrundale, J. (1998). Trends in cancer incidence and mortality in Scotland: description and possible explanations. Br j cancer, Vol.77 Suppl 3, pp. 1-54.  show abstract

Jones, M.E., Swerdlow, A.J., Griffith, M. & Goldacre, M.J. (1998). Risk of congenital inguinal hernia in siblings: a record linkage study. Paediatr perinat epidemiol, Vol.12, pp. 288-296.  show abstract

Jones, M.E., Swerdlow, A.J., Gill, L.E. & Goldacre, M.J. (1998). Pre-natal and early life risk factors for childhood onset diabetes mellitus: a record linkage study. Int j epidemiol, Vol.27, pp. 444-449.  show abstract

Jones, M.E., Swerdlow, A.J., Griffith, M. & Goldacre, M.J. (1998). Prenatal risk factors for cryptorchidism: a record linkage study. Paediatr perinat epidemiol, Vol.12, pp. 383-396.  show abstract

Jones, M.E. & Swerdlow, A.J. (1998). Bias in the standardized mortality ratio when using general population rates to estimate expected number of deaths. Am j epidemiol, Vol.148, pp. 1012-1017.  show abstract

Swerdlow, A.J. (1997). Risk of testicular cancer in cohort of boys with cryptorchidism (vol 314, pg 1507, 1997). Brit med j, Vol.315 (7116), pp. 1129-1129.

Carpenter, L.M., Swerdlow, A.J. & Fear, N.T. (1997). Mortality of doctors in different specialties: findings from a cohort of 20000 NHS hospital consultants. Occup environ med, Vol.54 (6), pp. 388-395.  show abstract

Barreto, S.M., Swerdlow, A.J., Smith, P.G. & Higgins, C.D. (1997). Risk of death from motor-vehicle injury in Brazilian steelworkers: a nested case-control study. Int j epidemiol, Vol.26 (4), pp. 814-821.  show abstract

Barreto, S.M., Swerdlow, A.J., Smith, P.G. & Higgins, C.D. (1997). A nested case-control study of fatal work related injuries among Brazilian steel workers. Occup environ med, Vol.54 (8), pp. 599-604.  show abstract

Swerdlow, A.J., De Stavola, B.L., Swanwick, M.A. & Maconochie, N.E. (1997). Risks of breast and testicular cancers in young adult twins in England and Wales: evidence on prenatal and genetic aetiology. Lancet, Vol.350 (9093), pp. 1723-1728.  show abstract

Swerdlow, A.J., Higgins, C.D. & Pike, M.C. (1997). Risk of testicular cancer in cohort of boys with cryptorchidism. Bmj, Vol.314 (7093), pp. 1507-1511.  show abstract

Swerdlow, A.J., Higgins, C.D. & Pike, M.C. (1997). Risk of testicular cancer in boys with cryptorchidism - Study was based on small number of cancers - Reply. Brit med j, Vol.315 (7120), pp. 1462-1463.

Swerdlow, A.J., Barber, J.A., Horwich, A., Cunningham, D., Milan, S. & Omar, R.Z. (1997). Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital. Br j cancer, Vol.75 (1), pp. 116-123.  show abstract

dos Santos Silva, I. & Swerdlow, A.J. (1996). Sex differences in time trends of colorectal cancer in England and Wales: the possible effect of female hormonal factors. Br j cancer, Vol.73 (5), pp. 692-697.  show abstract

Barreto, S.M., Swerdlow, A.J., Smith, P.G., Higgins, C.D. & Andrade, A. (1996). Mortality from injuries and other causes in a cohort of 21,800 Brazilian steel workers. Occup environ med, Vol.53 (5), pp. 343-350.  show abstract

Bataille, V., Bishop, J.A., Sasieni, P., Swerdlow, A.J., Pinney, E., Griffiths, K. & Cuzick, J. (1996). Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br j cancer, Vol.73 (12), pp. 1605-1611.  show abstract

Swerdlow, A.J., Jacobs, P.A., Marks, A., Maher, E.J., Young, T., Barber, J.C. & Vaughan Hudson, G. (1996). Fertility, reproductive outcomes, and health of offspring, of patients treated for Hodgkin's disease: an investigation including chromosome examinations. Br j cancer, Vol.74 (2), pp. 291-296.  show abstract

Swerdlow, A.J., De Stavola, B., Maconochie, N. & Siskind, V. (1996). A population-based study of cancer risk in twins: relationships to birth order and sexes of the twin pair. Int j cancer, Vol.67 (4), pp. 472-478.  show abstract

Grulich, A.E., Bataille, V., Swerdlow, A.J., Newton-Bishop, J.A., Cuzick, J., Hersey, P. & McCarthy, W.H. (1996). Naevi and pigmentary characteristics as risk factors for melanoma in a high-risk population: a case-control study in New South Wales, Australia. Int j cancer, Vol.67 (4), pp. 485-491.  show abstract

Ibison, J.M., Swerdlow, A.J., Head, J.A. & Marmot, M. (1996). Maternal mortality in England and Wales 1970-1985: an analysis by country of birth. Br j obstet gynaecol, Vol.103 (10), pp. 973-980.  show abstract

Silva, I.D. & Swerdlow, A.J. (1996). Reply to the letter from Rettig and Lemon. British journal of cancer, Vol.74 (9), pp. 1510-1510.

Peto, J., Easton, D.F., Matthews, F.E., Ford, D. & Swerdlow, A.J. (1996). Cancer mortality in relatives of women with breast cancer: the OPCS Study Office of Population Censuses and Surveys. Int j cancer, Vol.65 (3), pp. 275-283.  show abstract

Easton, D.F., Matthews, F.E., Ford, D., Swerdlow, A.J. & Peto, J. (1996). Cancer mortality in relatives of women with ovarian cancer: the OPCS Study Office of Population Censuses and Surveys. Int j cancer, Vol.65 (3), pp. 284-294.  show abstract

Peto, J., Easton, D.F., Matthews, F.E., Ford, D. & Swerdlow, A.J. (1996). Cancer mortality in relatives of women with breast cancer: The OPCS study. Int j cancer, Vol.65 (3), pp. 275-283.  show abstract

Easton, D.F., Matthews, F.E., Ford, D., Swerdlow, A.J. & Peto, J. (1996). Cancer mortality in relatives of women with ovarian cancer: The OPCS study. Int j cancer, Vol.65 (3), pp. 284-294.  show abstract

Jones, M.E. & Swerdlow, A.J. (1996). Bias caused by migration in case-control studies of prenatal risk factors for childhood and adult diseases. Am j epidemiol, Vol.143, pp. 823-831.  show abstract

Swerdlow, A.J. & Jones, M.E. (1996). Mortality during 25 years of follow-up of a cohort with diabetes. Int j epidemiol, Vol.25, pp. 1250-1261.  show abstract

Bataille, V., Sasieni, P., Cuzick, J., Hungerford, J.L., Swerdlow, A. & Bishop, J.A. (1995). Risk of ocular melanoma in relation to cutaneous and IRIS naevi. International journal of cancer, Vol.60 (5), pp. 622-626.

Swerdlow, A.J., English, J.S. & Qiao, Z. (1995). The risk of melanoma in patients with congenital nevi: a cohort study. J am acad dermatol, Vol.32 (4), pp. 595-599.  show abstract

Swerdlow, A.J., Cooke, K.R., Skegg, D.C. & Wilkinson, J. (1995). Cancer incidence in England and Wales and New Zealand and in migrants between the two countries. Br j cancer, Vol.72 (1), pp. 236-243.  show abstract

dos Santos Silva, I. & Swerdlow, A.J. (1995). Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use. Br j cancer, Vol.72 (2), pp. 485-492.  show abstract

Grulich, A.E., Swerdlow, A.J., dos Santos Silva, I. & Beral, V. (1995). Is the apparent rise in cancer mortality in the elderly real? Analysis of changes in certification and coding of cause of death in England and Wales, 1970-1990. Int j cancer, Vol.63 (2), pp. 164-168.  show abstract

Bliss, J.M., Ford, D., Swerdlow, A.J., Armstrong, B.K., Cristofolini, M., Elwood, J.M., Green, A., Holly, E.A., Mack, T. & MacKie, R.M., et al. (1995). Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies The International Melanoma Analysis Group (IMAGE). Int j cancer, Vol.62 (4), pp. 367-376.  show abstract

Ford, D., Bliss, J.M., Swerdlow, A.J., Armstrong, B.K., Franceschi, S., Green, A., Holly, E.A., Mack, T., MacKie, R.M. & Osterlind, A., et al. (1995). Risk of cutaneous melanoma associated with a family history of the disease The International Melanoma Analysis Group (IMAGE). Int j cancer, Vol.62 (4), pp. 377-381.  show abstract

Swerdlow, A.J., Storm, H.H. & Sasieni, P.D. (1995). Risks of second primary malignancy in patients with cutaneous and ocular melanoma in Denmark, 1943-1989. Int j cancer, Vol.61 (6), pp. 773-779.  show abstract

Swerdlow, A.J., Marmot, M.G., Grulich, A.E. & Head, J. (1995). Cancer mortality in Indian and British ethnic immigrants from the Indian subcontinent to England and Wales. Br j cancer, Vol.72 (5), pp. 1312-1319.  show abstract

Tomásek, L., Darby, S.C., Fearn, T., Swerdlow, A.J., Placek, V. & Kunz, E. (1994). Patterns of lung cancer mortality among uranium miners in West Bohemia with varying rates of exposure to radon and its progeny. Radiat res, Vol.137 (2), pp. 251-261.  show abstract

Parkinson, M.C., Swerdlow, A.J. & Pike, M.C. (1994). Carcinoma in situ in boys with cryptorchidism: when can it be detected?. Br j urol, Vol.73 (4), pp. 431-435.  show abstract

Tomásek, L., Swerdlow, A.J., Darby, S.C., Placek, V. & Kunz, E. (1994). Mortality in uranium miners in west Bohemia: a long-term cohort study. Occup environ med, Vol.51 (5), pp. 308-315.  show abstract

Newton, J.N., Swerdlow, A.J., dos Santos Silva, I.M., Vessey, M.P., Grahame-Smith, D.G., Primatesta, P. & Reynolds, D.J. (1994). The epidemiology of carcinoid tumours in England and Scotland. Br j cancer, Vol.70 (5), pp. 939-942.  show abstract

dos Santos Silva, I. & Swerdlow, A.J. (1993). Sex differences in the risks of hormone-dependent cancers. Am j epidemiol, Vol.138 (1), pp. 10-28.  show abstract

Swerdlow, A.J., Douglas, A.J., Vaughan Hudson, G. & Vaughan Hudson, B. (1993). Completeness of cancer registration in England and Wales: an assessment based on 2,145 patients with Hodgkin's disease independently registered by the British National Lymphoma Investigation. Br j cancer, Vol.67 (2), pp. 326-329.  show abstract

dos Santos Silva, I. & Swerdlow, A.J. (1993). Thyroid cancer epidemiology in England and Wales: time trends and geographical distribution. Br j cancer, Vol.67 (2), pp. 330-340.  show abstract

Swerdlow, A.J., Whittaker, S., Carpenter, L.M. & English, J.S. (1993). Mortality and cancer incidence in patients with dermatitis herpetiformis: a cohort study. Br j dermatol, Vol.129 (2), pp. 140-144.  show abstract

Tomásek, L., Darby, S.C., Swerdlow, A.J., Placek, V. & Kunz, E. (1993). Radon exposure and cancers other than lung cancer among uranium miners in West Bohemia. Lancet, Vol.341 (8850), pp. 919-923.  show abstract

Swerdlow, A.J., Douglas, A.J., Vaughan Hudson, G., Vaughan Hudson, B. & MacLennan, K.A. (1993). Risk of second primary cancer after Hodgkin's disease in patients in the British National Lymphoma Investigation: relationships to host factors, histology and stage of Hodgkin's disease, and splenectomy. Br j cancer, Vol.68 (5), pp. 1006-1011.  show abstract

Sheldon, C.D., Hodson, M.E., Carpenter, L.M. & Swerdlow, A.J. (1993). A cohort study of cystic fibrosis and malignancy. Br j cancer, Vol.68 (5), pp. 1025-1028.  show abstract

Swerdlow, A.J. (1993). Cohorts of insulin-treated patients with diabetes. Diabet med, Vol.10 (10), pp. 894-896.

Newton, J.A., Bataille, V., Griffiths, K., Squire, J.M., Sasieni, P., Cuzick, J., Bishop, D.T. & Swerdlow, A. (1993). How common is the atypical mole syndrome phenotype in apparently sporadic melanoma?. Journal of the american academy of dermatology, Vol.29 (6), pp. 989-996.

Head, J., Marmot, M.G. & Swerdlow, A.J. (1993). Cancer in Italian migrant populations England and Wales: mortality. Iarc sci publ, (123), pp. 166-177.

Swerdlow, A.J. (1993). Cancer in Italian migrant populations England and Wales: incidence. Iarc sci publ, (123), pp. 178-185.

Swerdlow, A.J. (1993). The epidemiology of testicular cancer. Eur urol, Vol.23 Suppl 2, pp. 35-38.

Swerdlow, A.J., Douglas, A.J., Hudson, G.V., Hudson, B.V., Bennett, M.H. & MacLennan, K.A. (1992). Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation. Bmj, Vol.304 (6835), pp. 1137-1143.  show abstract

Hoel, D.G., Davis, D.L., Miller, A.B., Sondik, E.J. & Swerdlow, A.J. (1992). Trends in cancer mortality in 15 industrialized countries, 1969-1986. J natl cancer inst, Vol.84 (5), pp. 313-320.  show abstract

Stephenson, J., Swerdlow, A.J., Devis, T. & Fuller, J.H. (1992). Recent trends in diabetes mortality in England and Wales. Diabet med, Vol.9 (5), pp. 417-421.  show abstract

Bataille, V., Cook, D., Cuzick, J., Edwards, R., Newton, J. & Swerdlow, A. (1992). Risk factors for melanoma. Melanoma research, Vol.2 (2), pp. 83-86.

Hawkins, M.M. & Swerdlow, A.J. (1992). Completeness of cancer and death follow-up obtained through the National Health Service Central Register for England and Wales. Br j cancer, Vol.66 (2), pp. 408-413.  show abstract

Grulich, A.E., Swerdlow, A.J., Head, J. & Marmot, M.G. (1992). Cancer mortality in African and Caribbean migrants to England and Wales. Br j cancer, Vol.66 (5), pp. 905-911.  show abstract

Grulich, A.E., Beral, V. & Swerdlow, A.J. (1992). Kaposi's sarcoma in England and Wales before the AIDS epidemic. Br j cancer, Vol.66 (6), pp. 1135-1137.  show abstract

SWERDLOW, A. (1991). MORTALITY AND CANCER INCIDENCE IN VIETNAMESE REFUGEES IN ENGLAND AND WALES - A FOLLOW-UP-STUDY. Int j epidemiol, Vol.20 (1), pp. 13-19.  show abstract

dos Santos Silva, I. & Swerdlow, A.J. (1991). Ovarian germ cell malignancies in England: epidemiological parallels with testicular cancer. Br j cancer, Vol.63 (5), pp. 814-818.  show abstract

Swerdlow, A.J. & dos Santos Silva, I. (1991). Geographic distribution of lung and stomach cancers in England and Wales over 50 years: changing and unchanging patterns. Br j cancer, Vol.63 (5), pp. 773-781.  show abstract

Swerdlow, A.J., Douglas, A.J., Huttly, S.R. & Smith, P.G. (1991). Cancer of the testis, socioeconomic status, and occupation. Br j ind med, Vol.48 (10), pp. 670-674.  show abstract

Beral, V., Bull, D., Jaffe, H., Evans, B., Gill, N., Tillett, H. & Swerdlow, A.J. (1991). Is risk of Kaposi's sarcoma in AIDS patients in Britain increased if sexual partners came from United States or Africa?. Bmj, Vol.302 (6777), pp. 624-625.  show abstract

Carpenter, L., Beral, V., Roman, E., Swerdlow, A.J. & Davies, G. (1991). Cancer in laboratory workers. Lancet, Vol.338 (8774), pp. 1080-1081.

Vågerö, D., Swerdlow, A.J. & Beral, V. (1990). Occupation and malignant melanoma: a study based on cancer registration data in England and Wales and in Sweden. Br j ind med, Vol.47 (5), pp. 317-324.  show abstract

dos Santos Silva, I. & Swerdlow, A.J. (1990). Thymus cancer epidemiology in England and Wales. Br j cancer, Vol.61 (6), pp. 899-902.  show abstract

Goss, B.D., Forman, D., Ansell, P.E., Bennett, V., Swerdlow, A.J., Burge, S. & Ryan, T.J. (1990). The prevalence and characteristics of congenital pigmented lesions in newborn babies in Oxford. Paediatr perinat epidemiol, Vol.4 (4), pp. 448-457.  show abstract

SWERDLOW, A. (1990). INTERNATIONAL TRENDS IN CUTANEOUS MELANOMA. Ann ny acad sci, Vol.609, pp. 235-251.

Swerdlow, A.J. (1990). International trends in cutaneous melanoma. Ann n y acad sci, Vol.609, pp. 235-251.

Swerdlow, A.J. (1990). Effectiveness of primary prevention of occupational exposures on cancer risk. Iarc sci publ, (103), pp. 23-56.

Morgan, M., Heller, R.F. & Swerdlow, A. (1989). Changes in diet and coronary heart disease mortality among social classes in Great Britain. Journal of epidemiology & community health, Vol.43 (2), pp. 162-167.

Swerdlow, A.J., English, J., MacKie, R.M., O'Doherty, C.J., Hunter, J.A., Clark, J. & Hole, D.J. (1989). Melanocytic nevus counts and melanoma. J am acad dermatol, Vol.20 (3), pp. 522-523.

Swerdlow, A.J. (1989). Interpretation of England and Wales cancer mortality data: the effect of enquiries to certifiers for further information. Br j cancer, Vol.59 (5), pp. 787-791.  show abstract

Swerdlow, A.J., Huttly, S.R. & Smith, P.G. (1989). Testis cancer: post-natal hormonal factors, sexual behaviour and fertility. Int j cancer, Vol.43 (4), pp. 549-553.  show abstract

Green, A. & Swerdlow, A.J. (1989). Epidemiology of melanocytic nevi. Epidemiol rev, Vol.11, pp. 204-221.

Swerdlow, A.J. & Melzer, D. (1988). The value of England and Wales congenital malformation notification scheme data for epidemiology: male genital tract malformations. J epidemiol community health, Vol.42 (1), pp. 8-13.  show abstract

Swerdlow, A.J. & Skeet, R.G. (1988). Occupational associations of testicular cancer in south east England. Br j ind med, Vol.45 (4), pp. 225-230.  show abstract

English, J.S., Swerdlow, A.J., Mackie, R.M., O'Doherty, C.J., Hunter, J.A., Clark, J. & Hole, D.J. (1988). Site-specific melanocytic naevus counts as predictors of whole body naevi. Br j dermatol, Vol.118 (5), pp. 641-644.  show abstract

SWERDLOW, A.J. (1988). CORRECTION. Brit med j, Vol.297 (6657), pp. 1172-1172.

SWERDLOW, A., HUNTER, J., ODOHERTY, C., MACKIE, R., ENGLISH, J., CLARK, J. & HOLE, D. (1988). SUNLAMPS AND THE RISK OF MELANOMA - REPLY. Brit med j, Vol.297 (6657), pp. 1194-1194.

Swerdlow, A.J., Huttly, S.R. & Smith, P.G. (1988). Is the incidence of testis cancer related to trauma or temperature?. Br j urol, Vol.61 (6), pp. 518-521.  show abstract

Swerdlow, A.J., English, J.S., MacKie, R.M., O'Doherty, C.J., Hunter, J.A., Clark, J. & Hole, D.J. (1988). Fluorescent lights, ultraviolet lamps, and risk of cutaneous melanoma. Bmj, Vol.297 (6649), pp. 647-650.  show abstract

Swerdlow, A.J., Huttly, S.R. & Smith, P.G. (1987). Testicular cancer and antecedent diseases. Br j cancer, Vol.55 (1), pp. 97-103.  show abstract

Swerdlow, A.J., Huttly, S.R. & Smith, P.G. (1987). Prenatal and familial associations of testicular cancer. Br j cancer, Vol.55 (5), pp. 571-577.  show abstract

ENGLISH, J. & SWERDLOW, A. (1987). THE RISK OF MALIGNANT-MELANOMA, INTERNAL MALIGNANCY AND MORTALITY IN XERODERMA-PIGMENTOSUM PATIENTS. Brit j dermatol, Vol.117, pp. 12-13.

Swerdlow, A.J. & Green, A. (1987). Melanocytic naevi and melanoma: an epidemiological perspective. Br j dermatol, Vol.117 (2), pp. 137-146.  show abstract

English, J.S. & Swerdlow, A.J. (1987). The risk of malignant melanoma, internal malignancy and mortality in xeroderma pigmentosum patients. Br j dermatol, Vol.117 (4), pp. 457-461.  show abstract

English, J.S., Swerdlow, A.J., MacKie, R.M., O'Doherty, C.J., Hunter, J.A., Clark, J. & Hole, D.J. (1987). Relation between phenotype and banal melanocytic naevi. Br med j (clin res ed), Vol.294 (6565), pp. 152-154.  show abstract

SWERDLOW, A. (1986). CANCER REGISTRATION IN ENGLAND AND WALES - SOME ASPECTS RELEVANT TO INTERPRETATION OF THE DATA. J roy stat soc a sta, Vol.149, pp. 146-160.

Jackson, M.B. & Swerdlow, A.J. (1986). Seasonal variations in cryptorchidism. J epidemiol community health, Vol.40 (3), pp. 210-213.  show abstract

Swerdlow, A.J., English, J., MacKie, R.M., O'Doherty, C.J., Hunter, J.A., Clark, J. & Hole, D.J. (1986). Benign melanocytic naevi as a risk factor for malignant melanoma. Br med j (clin res ed), Vol.292 (6535), pp. 1555-1559.  show abstract

Swerdlow, A.J. (1985). Seasonality of presentation of cutaneous melanoma, squamous cell cancer and basal cell cancer in the Oxford Region. Br j cancer, Vol.52 (6), pp. 893-900.  show abstract

ENGLISH, J., MACKIE, R., ODOHERTY, O., HUNTER, J., CLARK, J. & SWERDLOW, A. (1985). HIGH COUNTS OF NORMAL MELANOCYTIC NAEVI ARE A RISK FACTOR FOR CUTANEOUS MALIGNANT-MELANOMA. Brit j dermatol, Vol.113, pp. 19-20.

Swerdlow, A.J., English, J., MacKie, R.M., O'Doherty, C.J., Hunter, J.A. & Clark, J. (1984). Benign naevi associated with high risk of melanoma. Lancet, Vol.2 (8395), p. 168.

SWERDLOW, A.J. (1984). CORRECTION. Brit j cancer, Vol.49 (1), pp. 112-112.

SWERDLOW, A. (1984). EPIDEMIOLOGY OF CUTANEOUS MALIGNANT-MELANOMA. Clin oncolo, Vol.3 (3), pp. 407-437.

Swerdlow, A.J. (1983). Epidemiology of melanoma of the eye in the Oxford Region, 1952-78. Br j cancer, Vol.47 (2), pp. 311-313.

Swerdlow, A.J. (1983). Epidemiology of eye cancer in adults in England and Wales, 1962-1977. Am j epidemiol, Vol.118 (2), pp. 294-300.  show abstract

Swerdlow, A.J., Wood, K.H. & Smith, P.G. (1983). A case-control study of the aetiology of cryptorchidism. J epidemiol community health, Vol.37 (3), pp. 238-244.  show abstract

Swerdlow, A.J., Stiller, C.A. & Wilson, L.M. (1982). Prenatal factors in the aetiology of testicular cancer: an epidemiological study of childhood testicular cancer deaths in Great Britain, 1953-73. J epidemiol community health, Vol.36 (2), pp. 96-101.  show abstract

Swerdlow, A.J. & Rue, E.R. (1981). Part-time medical training: 15 years' experience in the Oxford region. Br med j (clin res ed), Vol.283 (6303), pp. 1371-1373.  show abstract

Swerdlow, A.J., McNeilly, R.H. & Rue, E.R. (1980). Women doctors in training: problems and progress. Br med j, Vol.281 (6242), pp. 754-758.

SWERDLOW, A. (1980). SUNSHINE AND MALIGNANT-MELANOMA - REPLY. Brit med j, Vol.280 (6207), pp. 112-113.

Swerdlow, A.J., Feychting, M., Green, A.C., Kheifets, L. & Savitz, D.A. Mobile Phones, Brain Tumours and the Interphone Study: Where are we now?. Environ health perspect., (119), pp. 1534-5.  show abstract

Pelttari, L.M., Khan, S., Vuorela, M., Kiiski, J.I., Vilske, S., Nevanlinna, V., Ranta, S., Schleutker, J., Winqvist, R., Kallioniemi, A., et al. RAD51B in Familial Breast Cancer. Plos one, Vol.11 (5), pp. e0153788-e0153788.

Swerdlow, A., Fletcher, O. & Orr, N. Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs). Sci rep., .

Swerdlow, A. & Orr, N. Functional mechanisms underlying pleiotropic risk alleles at the 19p13 1 breast-ovarian cancer susceptibility locus. Nat commun., .

Swerdlow, A. & Schoemaker, M. Length of FMR1 repeat alleles within the normal range does not substantially affect the risk of early menopause. Hum reprod., .

Swerdlow, A., Fletcher, O., Johnson, N. & Schoemaker, M. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation. Am j hum genet, .

Swerdlow, A., Fletcher, O., rahman, N. & schoemaker, M. Ten variants associated with risk of estrogen receptor negative breast cancer. Nat genet, .

Swerdlow, A., garcia-closas, M. & orr, N. rs2735383, located at a microRNA binding site in the 3’UTR of NBS1, is not associated with breast cancer risk. Scientific reports, .

Swerdlow, A. The Intracranial Distribution of Gliomas in Relation to Exposure From Mobile Phones: Analyses From the INTERPHONE Study. Am j epidemiol, .

Horne, H.N., Chung, C.C., Zhang, H., Yu, K., Prokunina-Olsson, L., Michailidou, K., Bolla, M.K., Wang, Q., Dennis, J., Hopper, J.L., et al. Fine-Mapping of the 1p11 2 Breast Cancer Susceptibility Locus. Plos one, Vol.11 (8), pp. e0160316-e0160316.

Law, P.J., Sud, A., Houlston, R.S., Orlando, G., Broderick, P., Speedy, H.E., Johnson, D.C., Kaiser, M. & Swerdlow, A. Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci. Scientific reports, .

Swerdlow, A., schoemaker, M.J. & bamber, J. Ultrasound Tomography Evaluation of Breast Density: A Comparison With Noncontrast Magnetic Resonance Imaging. Invest radiol., .

Swerdlow, A., schoemaker, M., wright, L.B., brook, M.N. & jones, M.E. A pooling project of studies participating in the National Cancer Institute Cohort Consortium. Cancer epidemiol biomarkers prev., .

Sud, A. Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility. Nature communications, .

Swerdlow, A. & Schoemaker, M. Circulating Anti-Müllerian Hormone and Breast Cancer Risk: A Study in Ten Prospective Cohorts. International journal of cancer, .

Disney-Hogg, L., Sud, A., Law, P., Cornish, A. & Houlston, R. Influence of obesity-related risk factors in the aetiology of glioma. British journal of cancer, .

Vijayakrishnan, J., Studd, J., Broderick, P., Kinnersley, B., Holroyd, A., Law, P., Greaves, M. & Houlston, R. Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia. Nature communications, .

Swerdlow, A. Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses. Cancer medicine, .

Swerdlow, A., Schoemaker, M., Wright, L., Brook, M. & Jones, M. Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women. Jama - journal of the american medical association, .

Swerdlow, A. & Cooke, R. Risk of meningioma in European patients treated with growth hormone in childhood: results from the SAGhE cohort. Jcem, .

Sud, A., Orlando, G., Law, P., Broderick, P., Cooke, R., Eeles, R., Kote-Jarai, Z., Swerdlow, A., Orr, N. & Houlston, R., et al. Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma. Blood, .

Went, M. & Houlston, R.S. Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma. Nature communications, .

Cornish, A., Claus, E., Broderick, P., Schildkraut, J., Houlston, R. & Wiemels, J. Genome-wide association analysis identifies a meningioma risk locus at 11p15 5. Neuro-oncology, .

Vijayakrishnan, J., Studd, J., Broderick, P., Kinnersley, B., Holroyd, A., Law, P., Greaves, M. & Houlston, R. Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia. Nature communications, .

Yang, Y., Wu, L., Shu, X., Lu, Y., Shu, X.-., Cai, Q., Beeghly-Fadiel, A., Li, B., Ye, F., Berchuck, A., et al. Genetic data from nearly 63,000 women of European descent predicts DNA methylation biomarkers and epithelial ovarian cancer risk. Cancer research, , pp. canres.2726.2018-canres.2726.2018.

Atkins, I., Kinnersley, B., Labreche, K., Schoemaker, M., Houlston, R. & Swerdlow, A. Transcriptome-wide association study identifies new candidate susceptibility genes for glioma. Cancer research, .  show abstract

Swerdlow, A. Shared heritability and functional enrichment across six solid cancers. Nature communications, .

Hein, R., Maranian, M., Hopper, J.L., Kapuscinski, M.K., Southey, M.C., Park, D.J., Schmidt, M.K., Broeks, A., Hogervorst, F.B., Bueno-de-Mesquit, H.B., et al. Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC). Plos one, Vol.7 (10).

Pal Choudhury, P., Wilcox, A.N., Brook, M.N., Zhang, Y., Ahearn, T., Orr, N., Coulson, P., Schoemaker, M.J., Jones, M.E., Gail, M.H., et al. Comparative validation of breast cancer risk prediction models and projections for future risk stratification. , .  show abstract

Pal Choudhury, P., Wilcox, A.N., Brook, M.N., Zhang, Y., Ahearn, T., Orr, N., Coulson, P., Schoemaker, M.J., Jones, M.E., Gail, M.H., et al. Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification. Jnci: journal of the national cancer institute, .  show abstract


Conferences

Orr, N., Jones, M., Maguire, S. & Swerdlow, A. (2018). Abstract 241: Contribution of female breast cancer predisposition SNPs to risk of male breast cancer, Presented at Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL, Epidemiology, .

Wentzensen, N.A., Poole, E., Arslan, A.A., Patel, A.V., Setiawan, V.W., Visvanathan, K., Weiderpass, E., White, E., Adami, H.-., Brinton, L.A., et al. (2015). Abstract 854: Ovarian cancer risk factors by histologic subtypes: evidence for etiologic heterogeneity, Presented at Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA, Epidemiology, .

Sutcliffe, A.G., Williams, C.L., Jones, M.E., Swerdlow, A.J., Davies, M.C., Jacobs, I. & Botting, B.J. (2015). Ovarian tumor risk in women after Assisted Reproductive Therapy (ART); 2.2 million person years of observation in Great Britain, Fertility and Sterility, Vol.104 (3), p.e37.

Sutcliffe, A.G., Williams, C., Boiling, B., Davies, M., Swerdlow, A. & Jacobs, I. (2013). ARE WOMEN WHO HAVE HAD HORMONAL ASSISTED REPRODUCTIVE THERAPY AT HIGHER RISK OF MORTALITY? A POPULATION BASED LINKAGE STUDY., FERTILITY AND STERILITY, Vol.100 (3), p.S165.

Andersson, U., Scwartzbaum, J., Wiklund, F., Sjostrom, S., Liu, Y., Tsavachidis, S., Ahlbom, A., Auvinen, A., Collatz-Laier, H., Feychting, M., et al. (2010). A COMPREHENSIVE STUDY OF THE ASSOCIATION BETWEEN THE EGFR AND ERBB2 GENES AND GLIOMA RISK, Presented at 9th Meeting of European-Association-of-NeuroOncology, Maastricht, NETHERLANDS. NEURO-ONCOLOGY, Vol.12, p.17.

Bennett, C., Macpherson, J.N., Jacobs, P.A., Orr, N., Ashworth, A., Swerdlow, A.J. & Murray, A. (2010). PCR assay for FMR1 used to determine the incidence of expansions in early menopause in the Breakthrough Generations Study, Presented at British Human Genetics Conference, Warwick, RI. JOURNAL OF MEDICAL GENETICS, Vol.47, p.S86.

Howell, S.J., Raynor, S., Swerdlow, A., Linton, K., Patnik, J., Carrigan, C. & Radford, J. (2010). A COMPREHENSIVE PROSPECTIVE NATIONAL DATABASE TO ENHANCE BREAST CANCER (BC) SCREENING SERVICES FOR HODGKIN LYMPHOMA (HL) SURVIVORS TREATED WITH SUPRADIAPHRAGMATIC RADIOTHERAPY (SRT) IN ENGLAND, HAEMATOLOGICA, Vol.95, p.S33.

Andersson, U., Osterman, P., Sjostrom, S., Johansen, C., Henriksson, R., Brannstrom, T., Broholm, H., Christensen, H.C., Ahlbom, A., Auvinen, A., et al. (2008). MNS16A MINISATELLITE GENOTYPES IN RELATION TO RISK Of GLIOMA AND MENINGIOMA TO GLIOBLASTOMA OUTCOME, Presented at 8th Congress of the European-Association-for-Neuro-Oncology (EANO), Barcelona, SPAIN. NEURO-ONCOLOGY, Vol.10 (6), p.1105.

Swerdlow, A.J., Higgins, C.D., Smith, P., Cunningham, D., Hancock, B.W., Horwich, A., Hoskin, P.J., Lister, A., Radford, J.A., Rohatiner, A.Z., et al. (2007). Myocardial infarction mortality risk after treatment for Hodgkin disease: A collaborative British cohort study, Presented at 7th International Symposium on Hodgkin Lymphoma, Cologne, GERMANY. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, Vol.92, p.1.

Bertram, C.G., Gaut, R.M., Barrett, J.H., Whitaker, L., Turner, F., Bataille, V., Silva, I.D., Swerdlow, A.J., Bishop, D.T. & Bishop, J.A., et al. (2003). An assessment of a variant of the DNA repair gene XRCC3 as a possible naevus or melanoma susceptibility genotype, Presented at Annual meeting of the British-Society-for-Investigative-Dermatology, UNIV SOUTHAMPTON, SOUTHAMPTON, ENGLAND. BRITISH JOURNAL OF DERMATOLOGY, Vol.148 (4), p.867.

Swerdlow, A.J. (2000). Epidemiology of chronic disease risks in relation to ultraviolet radiation exposure, Presented at International Workshop on Ultraviolet Radiation Exposure, Measurement and Protection, ST CATHERINES COLL, OXFORD, ENGLAND. RADIATION PROTECTION DOSIMETRY, Vol.91 (1-3), pp.19-23.

Swerdlow, A.J. (1999). Measurement of radiofrequency radiation exposure in epidemiological studies, Presented at International Workshop on Exposure Metrics and Dosimetry for EMF Epidemiology of the National Radiation Protection Board, CHILTON, ENGLAND. RADIATION PROTECTION DOSIMETRY, Vol.83 (1-2), pp.149-153.

Swerdlow, A.J. (1998). New research in testicular cancer epidemiology, Presented at 4th Germ Cell Tumour Conference, LEEDS, ENGLAND. GERM CELL TUMOURS IV, , pp.3-8.

Swerdlow, A.J. (1997). Skin cancer risks from ultraviolet lamps and sunbeds, Presented at International Congress on Skin Cancer and UV Radiation, BOCHUM, GERMANY. SKIN CANCER AND UV RADIATION, , pp.601-610.